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Abstract

APPROACHES TO IDENTIFY SURFACE PROTEINS OF ANAPLASMA
PHAGOCYTOPHILUM DENSE-CORED ORGANISMS AS ADHESINS TO HUMAN PSELECTIN GLYCOPROTEIN LIGAND-1
By Matthew James Troese
A Dissertation submitted in partial fulfillment of the requirements for the degree of
Doctor of Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2010
Major Director: Dr. Jason A. Carlyon, Ph.D.
Assistant Professor, Department of Microbiology and Immunology

Anaplasma phagocytophilum is an obligatory intracellular bacterium that infects
neutrophils to cause human granulocytic anaplasmosis. Sialyl Lewis x (sLex)-modified Pselectin glycoprotein ligand-1 (PSGL-1) is the confirmed receptor utilized by A.
phagocytophilum to bind and invade human neutrophils and myeloid cell lines. As an
obligate intracellular pathogen, the binding of A. phagocytophilum to a host cell receptor is
a prerequisite step for entry and replication, and thus its survival. However, the bacterial
adhesins mediating this process have yet to be identified. In this study, we sought to
xv

identify surface proteins of A. phagocytophilum as putative adhesins. A. phagocytophilum
undergoes a biphasic developmental cycle, transitioning between a smaller electron densecored cell (DC), which has a dense nucleoid, and a larger, pleomorphic electron lucent
reticulate cell (RC), which has a dispersed nucleoid. We determined that the respective
roles of the A. phagocytophilum DCs and RCs are adherence/infection and vacuolar
replication, respectively, which is a finding that is consistent with the life cycles of other
obligate intravacuolar pathogens that undergo biphasic development. Most importantly,
we demonstrated the A. phagocytophilum DC is responsible for recognizing human PSGL1. To identify surface proteins as putative adhesins we tested a variety of approaches.
Three different computer prediction programs were compared, resulting in identification of
As a more direct means to identify A.

16 to 130 potential membrane proteins.

phagocytophilum surface proteins as PSGL-1 adhesins, several affinity capture approaches
were tested. We used commercially available recombinant human PSGL-1 (rhPSGL-1) to
try and capture adhesins by crosslinking and affinity purification. We were unsuccessful,
but nevertheless gained insight into the binding properties of A. phagocytophilum. We
next chose to take a broader approach to identify outer membrane proteins of the adherent
DC by biotinylation. In the process we developed new density-gradient centrifugation
approaches which successfully purified an RC-enriched population as well as a mixed
population of RC and DC organisms.

Results from this work demonstrate that A.

phagocytophilum DC organisms are responsible for binding PSGL-1. Additionally, the
results obtained thus far of gradient-purified bacteria will serve as a foundation for future
experiments in identifying surface and developmental form specific proteins.
xvi

CHAPTER 1: Introduction

History and Ecology of Anaplasma phagocytophilum
The family Anaplasmataceae consists of obligate intracellular bacterial pathogens
that are distinctive in their ability to replicate in vacuoles within the cytoplasm of a host
cell.

Located within the order Rickettsiales, five members within the family

Anaplasmataceae, consisting of Anaplasma phagocytophilum, Ehrlichia chaffeensis,
Ehrlichia ewingii, Ehrlichia canis and Neorickettsia sennetsu are capable of causing
disease in humans.

Human infection by these pathogens is generally referred to as

"ehrlichiosis." Although members of the family Anaplasmataceae were first recognized as
early as 1910, reported cases on human ehrlichiosis published from the CDC as a notifiable
disease has only occurred since 1999 (1, 183).
First identified in 1932 as a veterinary agent, the tick-transmitted obligate
intracellular bacterium A. phagocytophilum has become an increasingly recognized threat
since 1994, when it was discovered to infect humans (34, 43). With the support of DNA
sequencing and genetic analysis of 16S rRNA and groESL genes, three former agents,
Ehrlichia phagocytophila, Ehrlichia equi and human granulocytic ehrlichiosis (HGE)
agent that were originally thought unique have since been reclassified in 2001 as the single
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agent, A. phagocytophilum (42). A. phagocytophilum infection in humans is now termed
human granulocytic anaplasmosis (HGA).
A. phagocytophilum is transmitted by Ixodes ticks, specifically by I. scapularis in
the Northeast and upper Midwest United States, I. pacificus in the Western United States,
I. ricinus in Europe and I. persulcatus in Asia (56, 170).

In the United States, A.

phagocytophilum is maintained in a transmission cycle between its tick vector and small
mammals, the primary of which is the white-footed mouse (Peromyscus leucopus) (56,
169). Acquisition of A. phagocytophilum by ticks occurs during a blood meal of an
infected mammalian host, as transovarial transmission does not occur. Nonetheless, once
a tick becomes infected transstadial transmission does occur as the tick molts from the
larva, nymph and to the adult stage (56). The overall life cycle of Ixodes ticks and
transmission potential of A. phagocytophilum is outlined in Figure 1A. Humans are not
the intended host of ticks, but are susceptible to infection if fed upon by an infected tick.
Upon tick attachment, transmission of A. phagocytophilum to a murine host can occur
within 24 hours (40).

Epidemiology
The majority of reported HGA cases within the United States occur primarily in
northern California, the upper Midwest, and the Northeast (119). This correlation is also
seen in canines (Fig. 1B) as evidenced by antibodies to A. phagocytophilum (24, 129). The
number of HGA cases reported to the CDC was an average of 0.23 cases per 100,000
people in 2006 (118). However, exposure to this pathogen in endemic areas is presumably
2

Figure 1.

Life cycle of Ixodes ticks and threat of A. phagocytophilum exposure.

(A) Life cycle of Ixodes species of tick. Adult females lay uninfected eggs, as transovarial
transmission does not occur with A. phagocytophilum. The uninfected larval ticks hatch
from eggs and acquire their first blood meal. Once a tick acquires A. phagocytophilum
from a host, it will remain infected throughout its life cycle as transstadial transmission
does occur. Although not the intended host of ticks, humans, canines and other mammals
can become infected if fed upon by an infected tick. (B) Potential threat of exposure to A.
phagocytophilum. Map indicates by county exposure to A. phagocytophilum as evidenced
by antibodies detected in canines. Canines are more frequently exposed to tick bites than
humans, allowing them to serve as sentinels in determining risk of human exposure and
infection within particular geographic areas. Gray shading indicates no results (<10), and
white indicates no canines reported as positive (0%). Remaining colors are as follows:
0.01 - 0.49% (pale green), 0.5 - 1.0% (lichen), 1.1 - 5.0% (kelly green) and 5.1 - 40% (dark
moss) (24).
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much greater as human serological studies in Wisconsin and New York suggest exposure
is as high as 15% to 36%, respectively (4, 12). An average of 35 cases per 100,000 people
was reported over a three-year period in Connecticut, making A. phagocytophilum the
second most common tick-transmitted pathogen in this state (82). Serological data clearly
demonstrates transmission of this pathogen is high; however the occurrence of diagnosed
disease after exposure is generally less frequent.

Clinical features and treatment
Clinical manifestations of HGA range in severity from subclinical or mild infection
to severe or even fatal disease. Non-specific symptoms of A. phagocytophilum include
malaise, fever, myalgia, and headache.

Rarely does rash occur along with infection.

Laboratory tests typically identify irregularities, which include thrombocytopenia,
leukopenia, anemia and elevated liver enzymes. Pathology includes inflammation of the
liver, slight lymphoid depletion, hyperplasia and hemophagocytosis. Severe complications
include prolonged fever, shock, confusion, seizures, pneumonitis, acute renal failure,
hemorrhages and rhabdomyolysis (41). Although many infections are asymptomatic and
may be self-limiting, it is estimated half of all symptomatic individuals require
hospitalization, with up to 7% admitted to intensive care (10, 43). HGA has an estimated
mortality rate of about 1%. Mortality has occurred from opportunistic infections and the
severity of disease generally increases with age and immunosuppressed individuals (10).
The hallmark of HGA infection is the presence of intravacuolar colonies termed
morulae, located within the cytoplasm of peripheral granulocytes (149). The term morulae
5

extends from the punctuate staining of A. phagocytophilum, which looks like mulberries
when viewed under a light microscope with Giemsa stains (Fig. 2A). Morulae can be
detected in blood smears of 25-75% of patients with HGA within the first week of
infection, although sometimes only 0.1% of neutrophils will be infected (170). Polymerase
chain reaction (PCR) also has a high detection rate of 67-90% (44). If HGA is identified
or suspected, treatment with doxycycline will usually resolve infection within 1-2 days
(11, 13). After treatment, detection of A. phagocytophilum by Giemsa stains and PCR will
decrease. Nonetheless, some individuals have reported to display symptoms of fatigue,
fever and chills 1-3 years after treatment (142).
In addition to A. phagocytophilum, the causative agent of Lyme disease - Borrelia
burgdorferi - is also transmitted by Ixodes spp. ticks. As a consequence it is not surprising
that coinfection of ticks and simultaneous transmission of A. phagocytophilum and B.
burgdorferi to humans can occur (98, 127). Coinfection contributes to more clinical
manifestations than those observed with B. burgdorferi or A. phagocytophilum infection by
themselves (92).

In vitro studies show coinfection results in higher cytokine and

chemokine production, resulting in impaired barrier functions of human brain
microvascular endothelial cells (59).

If coinfection is suspected, treatment with

doxycycline is successful in treating both infections (44).

Intracellular survival and pathogenesis
A remarkable characteristic of A. phagocytophilum is its ability to replicate within
neutrophils, the primary effector cell of microbial killing (158). A. phagocytophilum
6

Figure 2. Examples of A. phagocytophilum morulae in tissue culture cells. (A) Giemsa
stain. Morulae (smaller dark staining purple vacuoles) can be seen within the cytoplasm of
the host cells. Within some morulae the punctuate appearance of individual organisms
(indicated by arrows) can be seen. (B) Immunofluorescence. Organisms within morulae
are detected with antiserum to Msp2(P44), the most abundant surface protein of A.
phagocytophilum. Thick and thin dashed lines delineate the host cell and host cell nucleus
membranes, respectively. (C) Transmission electron microscopy (8,200x). Morulae and
individual organisms are easily distinguished. Both the electron dense-cored cell (DC) and
pleomorphic electron lucent reticulate cell (RC) can be distinguished. All images are of A.
phagocytophilum growing in HL-60 cells. N indicates host cell nucleus.

7

8

survival is largely dependent on neutrophils as their depletion in mice will reduce the
bacterial load (20).

Infection of mouse neutrophils also results in secretion of the

chemokine interleukin-8 (IL-8), which promotes additional neutrophils to migrate to sites
of infection, thereby further promoting A. phagocytophilum survival (5). It has also been
more recently demonstrated that A. phagocytophilum can infect human endothelial and
megakaryocytic cell lines (64, 73).
Infection of human neutrophils is linked to its surface expression of platelet selectin
glycoprotein ligand-1 (PSGL-1), a selectin ligand (58, 74). The promyelocytic leukemia
cell line HL-60 expresses PSGL-1 and supports A. phagocytophilum infection (57).
This cell line represents the standard for in vitro cultivation of A. phagocytophilum. After
binding to PSGL-1, A. phagocytophilum enters the cell and resides within a host cellderived vacuole. Within this vacuole A. phagocytophilum will replicate by binary fission.
The terms morulae, vacuole and inclusion are synonymous with each other. During
intracellular development A. phagocytophilum undergoes a biphasic developmental cycle
consisting of two distinct morphological forms.

These consist of a smaller

adherent/infectious dense-cored cell (DC) and a larger noninfectious reticulate cell (RC).
The focus of Chapter 2 is to determine the pathobiological roles of these two forms. The
two forms can only be distinguished by transmission electron microscopy (TEM) (Fig.
2C), as no form specific proteins have been identified to differentiate between RCs and
DCs by indirect immunofluorescence assay (IFA). During intracellular replication A.
phagocytophilum has adapted to utilizing host components for survival, such as acquiring
host cell amino acids for use, as well as incorporating host cell cholesterol into its
9

membrane (45, 193). This dependence on the host cell has reduced the genome to 1.47
Megabases (Mb).
To survive within such a hostile intracellular environment, A. phagocytophilum
utilizes multiple strategies. Upon entry into human myeloid cells, the A. phagocytophilum
occupied vacuole recruits Rab GTPases that are associated with recycling endosomes (78).
Rabs are responsible for organelle identity and regulate endosome maturation.

By

disguising its self as a recycling endosome, the A. phagocytophilum vacuole prevents its
maturation to a mature endosome and avoids lysosomal fusion. This has been further
demonstrated by exclusion of early endosome markers from the occupied-vacuole, such as
the transferrin receptor, Rab 5, and early endosome antigen 1 (121).

The A.

phagocytophilum vacuole also does not acquire Lysosomal-associated membrane protein 1
(LAMP-1) associated with late endosome and does not acquire vacuole-type H+ ATPases,
which are required for vacuolar acidification (30, 185).
Typically when bacteria are phagocytosed into neutrophils, toxic oxygen
intermediates are delivered into the phagosome.

This delivery is controlled by the

assembled nicotinamide adenine dinucleotide phosphate (NADPH) oxidase complex on the
phagosome membrane. Yet, A. phagocytophilum inhibits transcription of genes encoding
for components of the NADPH oxidase complex, preventing formation and thus delivery
of toxic oxygen intermediates into the phagosome (31). In addition, the ability to scavenge
exogenous superoxide (O2−) and rapidly detoxify O2− is another strategy A.
phagocytophilum employs for its survival (28).

10

The type IV secretion system (T4SS) encoded by A. phagocytophilum is also
directly responsible for promoting its survival through delivery of bacterial proteins into
the host cell (150). Three T4SS proteins have been identified in A. phagocytophilum;
AnkA, Ats-1 and AptA (101, 132, 165). AnkA, which contains ankyrin repeats is the best
studied and characterized of these proteins. Within minutes of organisms binding to a
naїve cell and before bacterial entry occurs, AnkA is injected into the cytoplasm of the host
cell where it is phosphorylated by the Abl-1 tyrosine kinase (81, 101). After injection,
AnkA enters the host cell nucleus and modifies gene transcription by directly binding to
chromatin (54).

Although few bacterial virulence factors have been identified, A.

phagocytophilum can inhibit host cell apoptosis through multiple pathways (30, 95, 148).
A. phagocytophilum infection has also been documented to deacetylate histones (52).
Changes in histone modification presumably have a direct effect on gene expression by
changing chromatin structure, resulting in compacted chromatin, which limits access to
transcriptional activation.

All of these effects on the host cell presumably occur to

promote intracellular survival and allow for increased replication time in neutrophils, as
peripheral blood neutrophils generally only survive for several days.

Immunopathology
During human infection the percentage of infected neutrophils can be exceptionally
low; nevertheless the pathology can be severe. This discrepancy between the low level of
bacteria during infection and high histopathology has always pointed to immune effectors
as the primary cause of disease. Cytokines produced during human, mouse, horse and dog
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infections are similar (97). The most prominent cytokine produced during infection is
interferon-γ (IFNγ). Infection models have demonstrated that IFNγ knockout mice do not
develop histopathological lesions, regardless of a 5-8 fold increase in the level of
organisms. In comparison, when IL-10 knockout mice which lack the ability to repress
IFNγ production are infected with A. phagocytophilum the bacterial load is identical to a
wild type control, but the level of histopathology is considerably more severe (110). This
demonstrates that histopathologic injury is not directly dependent on the bacterial load, but
instead depends on host cell immune responses.
The immune system pathways that are critical for controlling and eventually
clearing A. phagocytophilum infections have not been fully elucidated.

When A.

phagocytophilum is repeatedly passaged in severe combined immunodeficiency (SCID)
mice, the virulence of A. phagocytophilum can increase and can eventually kill the SCID
mouse (20).

This suggests that intact immune systems are more beneficial than

disadvantageous. In addition, when various components of the innate immune system
were studied in knockout mice, it was demonstrated that inducible nitric oxide (iNOS),
phagocyte NADPH oxidase (PHOX), tumor necrosis factor, toll-like receptor (TLR)2,
TLR4 and myeloid differentiation factor 88 (MyD88) do not contribute to controlling
infection (182). Moreover, some of these intact innate immune features during infection
actually contributed to increased inflammation and hepatic injury (157). One feature that
+

is important for eventual elimination is CD4 T cells. But oddly, this clearance occurs in
the absence of perforin, Fas/FasL and Th1 cytokines such as IL-12 and IFNγ, which are
effectors generally required for eliminating intracellular pathogens (20). The unusual
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feature of A. phagocytophilum to infect neutrophils and its means to avoid pathways that
successfully eliminates other intracellular pathogens likely points towards an equally
distinctive and untraditional means required for controlling infection that has yet to be
fully understood.

Bacterial adhesion-receptor interactions
Bacterial adhesins are the "tip of the sword" when it comes to interacting with host
cell receptors, and are a necessity for the initial steps of colonization and infection. For
obligate intracellular pathogens, adhesion and entry into a host cell is more than just an
arbitrary event, it is a requirement for survival. Bacterial adhesins are typically classified
as fimbrial or afimbrial. Fimbrial adhesins are those that protrude from the surface of
bacteria, such as various types of pili. Afimbrial adhesins are those that do not extend
beyond the organism and are surface bound (90, 139).
Bacterial adhesins typically recognize specific structural requirements of their
respective receptors, which usually restricts the organism to specific tissues or cell types
(48). Nevertheless, there are exceptions such as the family of variable outer membrane
opacity-associated (Opa) proteins of Neisseria that recognize multiple human cell surface
receptors (181). Adhesins can bind two types of receptors, protein and carbohydrate (49).
Carbohydrate moieties can be located on both glycoproteins and glycolipids (39, 49). The
respective bacterial adhesins for a given receptor can also be protein or carbohydrate. In
fact, the majority of confirmed or suspected bacterial adhesins from many different species
have been identified as proteinaceous (7, 33, 90, 109, 139, 143, 152, 186, 199). Even
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though most adhesins are protein, the importance of bacterial glycosylation and its role in
adhesion has also been established (18, 37, 53, 75, 176). Characterization of adhesins is
crucial to understanding how bacteria initially colonize and infect various cells and tissue,
and the host cell responses they elicit. Adhesins are also ideal targets for the development
of vaccines to prevent infection and colonization by bacteria (35, 93, 94, 191).

A. phagocytophilum adhesins are likely surface exposed proteins
Several observations suggest that the A. phagocytophilum adhesin(s) are located
within the outer membrane and are directly surface exposed. Foremost, organisms that
have been incubated with an excess of membrane impermeable crosslinkers (crosslink
surface proteins), exhibit decreased binding to HL-60 cells, which implies that the
crosslinkers are either binding to or sterically hindering the adhesin(s) (unpublished data).
In addition, A. phagocytophilum organisms that have been fixed with paraformaldehyde
(PFA) still bind specifically to PSGL-1 (194), which demonstrates that the adhesin(s)
presumably are surface exposed, as fixed organisms could not upregulate or remodel
protein surface structures. Also, A. phagocytophilum organisms bind equally well to HL60 cells at 4, 23, and 37°C, which demonstrates that binding is not temperature dependent.
Furthermore, when other obligate intracellular bacterial pathogens that undergo biphasic
development such as Chlamydia are considered, the infectious form is metabolically inert
due to compacted chromatin (3).

This would imply the infectious DC form of A.

phagocytophilum does not possess the ability to upregulate surface proteins in response to
environmental stimuli. Indeed, when A. phagocytophilum organisms are isolated from
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mammalian HL-60 cells and incubated with mammalian and bovine endothelial cell lines,
they are susceptible to infection (124). Additionally, we have observed by TEM that the
infectious DC form of A. phagocytophilum isolated from HL-60 cells binds to mouse mast
cells (unpublished data). This strongly implicates the adhesin(s) for multiple cells types
are likely expressed on the DC surface.
To further characterize the nature of the A. phagocytophilum adhesin(s), former
Carlyon lab member Jonathan Sims extensively tested the binding properties required for
adhesion to the confirmed human receptor, PSGL-1. Considering the adhesin-receptor
interactions discussed in the previous section, organisms were pretreated with enzymes or
oxidative agents and then tested for their ability to bind PSGL-1. When organisms were
treated with lipase to remove lipids, sodium periodate to degrade carbohydrates and
pronase to degrade proteins, only pretreatment with pronase caused a significant reduction
in bacterial binding (unpublished data).

These experiments strongly suggest that the

adhesin(s) is proteinaceous in nature.

Taken as a whole, these experiments and

observations point to the A. phagocytophilum adhesin(s) as surface exposed proteins.

Major surface protein 2 (Msp2[P44]): The Dominant surface protein
Although the surface of A. phagocytophilum acts as a crucial interface for
adherence to host cells, it has not yet been characterized in depth.

One of the few

confirmed and most studied surface proteins of A. phagocytophilum is the Msp2(P44)
family that encode 42- to 49-kilodalton (kDa) transmembrane proteins that carry
immunodominant B-cell epitopes.

Msp2(P44) proteins share a common structure
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consisting of a central hypervariable region (HVR) flanked by conserved N- and Cterminal regions. The HVRs exhibit strong predictability of being surface exposed, thus
providing potential sources for surface phenotype diversity (84, 126, 200).

The A.

phagocytophilum Msp2(P44) proteins are orthologous to those encoded by the Anaplasma
marginale Msp2 family (134). A. marginale remains within its ruminant host for the
animals lifetime, and Msp2 antigenic variation is directly linked to the bacterium's
persistence in vivo (46, 134). Likewise, the A. phagocytophilum Msp2(P44) proteins are
believed to afford antigenic variation (43, 56), and a study that followed the msp2(p44)
transcriptional profile of a clonal population over the course of equine infection supports
this hypothesis (105).
Diversity in Msp2(P44) results from RecF-mediated gene conversion of a single
genomic msp2(p44) expression site by partially homologous sequences (14-16, 106, 107).
The A. phagocytophilum genome contains a large reserve (113 in the sequenced strain, HZ)
of msp2(p44) genes or gene fragments lacking 5'- or 3'-terminal sequences (45). The gene
fragments have been referred to as “functional pseudogenes” (105) because, rather than
being nonfunctional fragments on their way to elimination, they recombine into the
msp2(p44) expression site to yield full-length msp2(p44) paralogs (15, 16, 105, 106).
Proteomic

characterization

of

Msp2(P44)

paralogs

revealed

the

protein

is

posttranslationally modified into multiple isoforms and is glycosylated (155, 174).
Msp2(P44) is also constitutively expressed throughout the developmental cycle (56) and
can function as a porin (80).
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Although some evidence suggests that Msp2(P44) acts as an adhesin (136, 184),
the data has never been overwhelmingly convincing.

The biggest argument against

Msp2(P44) functioning as an adhesin is the constant variation of the surface exposed HVR,
which would have to remain constant to routinely bind the same receptor.

During

mammalian infection, the immune response to Msp2(P44) is very well conserved and has
been tested as a suitable antigen for laboratory diagnosis (85, 200). When mice are
vaccinated with lysates of purified organisms or passively administered antibodies and
then challenged by syringe- or tick-transmission, the mice are provided considerable but
not complete immunity to infection from A. phagocytophilum (166). The mice that were
immunized with lysates of purified organisms generate strong antibody responses to
Msp2(P44). Given the strong antibody response to Msp2(P44) and the abundance of the
protein on the surface of A. phagocytophilum, infection should have been largely
preventable if Msp2(P44) was a true adhesin. A more probable explanation is antibodies
to Msp2(P44) coat the surface of the organism and sterically hinder true adhesin(s), thus
resulting in incomplete protection.

Other surface proteins of A. phagocytophilum
The only other study to date that set out to identify additional surface proteins of A.
phagocytophilum was conducted by Yan Ge and Yasuko Rikihisa (55). Using a membrane
impermeable biotin reagent, 14 putative A. phagocytophilum surface proteins were labeled,
recovered, and identified by mass spectrometry (MS).

Biotinylation has become a

valuable and reliable technique to identify the cell surface protein composition of many
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organisms (25, 88, 138, 141, 153). From this approach, only 2 of the 14 identified proteins
were further confirmed as surface exposed. The two newly identified surface proteins are
designated Asp55 and Asp62.

This study demonstrates biotinylation can serve as a

reasonable approach to use for identification of A. phagocytophilum surface proteins.
Although this study was the first to further characterize the surface of A.
phagocytophilum, the data from this experiment does have several limitations. First, both
a mixture of the adherent/infectious DC and non-adherent/noninfectious RC forms were
used as the substrate for biotinylation. Consequently, it cannot be determined whether the
identified proteins are expressed on only one or both developmental forms. As we will
demonstrate in Chapter 2, we believe the adhesin(s) are likely upregulated on the
adherent/infectious DC form. Second, recovered biotinylated proteins were resolved by 1
dimensional sodium dodecyl sulfate - polyacrylamide gel electrophoresis (1D SDSPAGE), which yielded many protein bands of interest from which only 7 were chosen for
analysis. Since only a select few bands were analyzed, many surface proteins may not
have been identified. Third, it has been demonstrated that membrane impermeable biotin
reagents can gain access through porins to label inner membrane proteins (25). Some of
the identified proteins in this study possessed characteristics of integral surface membrane
proteins, while others did not. The dominant surface protein of A. phagocytophilum
Msp2(P44), has been shown to function as a porin (80), which may have potentially
allowed for labeling and recovery of inner membrane proteins. In Chapter 5, we use
biotinylation as a means to identify surface proteins of A. phagocytophilum, but do so
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using improved methods to address the above limitations and to identify a more
comprehensive list of surface proteins on the adherent/infectious DC form.

A. phagocytophilum adhesion to sLex-modified PSGL-1
As an obligate intracellular pathogen, the binding of A. phagocytophilum to a host
cell receptor is a prerequisite step for entry and replication, and thus its survival. However,
the bacterial adhesin(s) mediating this process have yet to be identified, and therefore
presents a significant gap in our understanding of A. phagocytophilum pathogenesis. The
hallmark characteristic of A. phagocytophilum infection is neutrophil colonization. It has
also been documented A. phagocytophilum can infect human bone marrow progenitor cells
(89). The uncommon tropism for neutrophils as well as neutrophil precursor cells suggest
that a specific receptor is targeted by A. phagocytophilum. The receptor has since been
identified as platelet selectin glycoprotein ligand-1 (PSGL-1) and the tetrasaccharide sialyl
Lewis x (sLex), which modifies the PSGL-1 N-terminus (58, 74). PSGL-1 is highly
expressed on neutrophils, where its function is to adhere to inflamed endothelial cells
(117). Human PSGL-1 is a homodimer consisting of two 120-kDa subunits connected by a
disulfide bond and is coated with O-glycans (Fig. 3A).

The region critical for A.

phagocytophilum binding is located on the N-terminal region of PSGL-1.

The

promyelocytic leukemia cell line HL-60 expresses sLex-modified PSGL-1 and is the
standard for supporting A. phagocytophilum infection in vitro (57).
Three specific determinants are essential for A. phagocytophilum binding. The
carbohydrate components include α2,3-linked sialic acid and α1,3-linked fucose of sLex.
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The protein component is the amino acid sequence YEYLDYDFLPE, which is located in
the PSGL-1 N-terminus (Fig. 3B) (144, 194). Antibody blocking or chemical removal of
any one of these three determinants will significantly reduce A. phagocytophilum binding
(58, 74, 154, 194).

When sLex and the PSGL-1 N-terminal peptide region are

independently coupled to a microsphere, A. phagocytophilum binding still occurs. This
indicates that sLex does not have to be presented directly on PSGL-1 (194).
From this data several adhesin scenarios are proposed for A. phagocytophilum
adhering to PSGL-1 (Fig. 4). First, A. phagocytophilum may express one adhesin with
multiple domains which bind the PSGL-1 N-terminal peptide, fucose, and sialic acid on
one PSGL-1 molecule (Fig. 4A).

Second, one adhesin with multiple domains could

simultaneously bind the PSGL-1 N-terminal peptide on one PSGL-1 molecule and fucose
and sialic acid presented on another glycoprotein (Fig. 4B). Third, A. phagocytophilum
could also express several adhesins each of which individually bind the PSGL-1 Nterminal peptide, fucose, and sialic acid on one PSGL-1 molecule (Fig. 4C). Fourth,
individual adhesins could bind the PSGL-1 N-terminal peptide on one PSGL-1 molecule
and fucose and sialic acid presented on another glycoprotein (Fig. 4D). The scenarios in
which adhesins bind sLex directly presented on PSGL-1 (Fig. 4A and C) are preferred as
they result in better binding (194). Higher levels of sLex-modified PSGL-1 expression also
support better binding (194).
Although these scenarios represent basic binding models, A. phagocytophilum
adhesion could be more complex. We cannot exclude the possibility a single adhesin as
represented in the models could be in reality a complex of 2 or more proteins. Regardless
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Figure 3.

Model of human PSGL-1 and the determinants recognized by A.

phagocytophilum.

(A) Human PSGL-1 is a homodimer consisting of two 120-kDa

subunits connected by a disulfide bond. PSGL-1 is decorated with various serine- and
threonine-linked oligosaccharides (O-glycans). The region critical for A. phagocytophilum
binding is located on the N-terminus of PSGL-1 indicated by the black dashed box.
(B) Model of the PSGL-1 N-terminal peptide region that is essential for A.
phagocytophilum binding. Critical residues include the amino acid region highlighted in
pink of the peptide backbone, as well as α2,3-sialic acid (blue diamond) and α1,3-fucose
(red triangle) of the tetrasaccharide sLex.
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Figure 4. A. phagocytophilum adhesion scenarios. A. phagocytophilum binding to sLexmodified PSGL-1 may occur by several different mechanisms. (A) A. phagocytophilum
may express one adhesin with multiple domains that bind the PSGL-1 N-terminal peptide,
fucose, and sialic acid on one PSGL-1 molecule. (B) One adhesin could simultaneously
bind the PSGL-1 N-terminal peptide on one PSGL-1 molecule and fucose and sialic acid
presented on another glycoprotein. (C) A. phagocytophilum could express several adhesins
each of which individually bind the PSGL-1 N-terminal peptide, fucose, and sialic acid on
one PSGL-1 molecule. (D) Individual adhesins could bind the PSGL-1 N-terminal peptide
on one PSGL-1 molecule and fucose and sialic acid presented on a another glycoprotein.
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of how adhesion occurs, identification of surface proteins as putative adhesin(s) will allow
greater insight into A. phagocytophilum pathogenesis.

As individuals continue to

participate in outdoor activities, exposure to this pathogen will continue to increase,
making the characterization of surface proteins of A. phagocytophilum crucial to
understanding their role in adhesion, which may serve as potential drug and vaccine targets
to treat or prevent HGA.

Research objectives
As an obligate intracellular pathogen, the binding of A. phagocytophilum to a host
cell receptor is a prerequisite step for entry and survival. We know that the susceptibilities
of human neutrophils and promyelocytic HL-60 cells to A. phagocytophilum are linked to
bacterial usage of sLex-modified PSGL-1 as the receptor for adhesion and entry. However,
the bacterial adhesin(s) mediating this process have yet to be identified. The overall goal
and work presented here seeks to identify surface proteins of A. phagocytophilum as
putative adhesins.

To undertake this objective, we first determined when during A.

phagocytophilum development the PSGL-1 targeting adhesins are expressed. We next
tested several affinity-based approaches to try to capture PSGL-1 adhesin(s). Lastly, we
developed new density-gradient centrifugation approaches to purify A. phagocytophilum
organisms.
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CHAPTER 2: A. phagocytophilum Dense-Cored Organisms Mediate
Cellular Adherence through Recognition of Human P-Selectin
Glycoprotein Ligand-1

INTRODUCTION
Sialyl Lewis x (sLex)-modified P-selectin glycoprotein ligand-1 (PSGL-1)
is the confirmed receptor utilized by A. phagocytophilum to bind and invade human
neutrophils, bone marrow progenitors, and myeloid cell lines (58, 74).

A.

phagocytophilum binding to PSGL-1 requires cooperative recognition of the N-terminal
primary amino acid sequence and the α2,3-linked sialic acid and α1,3-linked fucose of sLex
(29, 194). This complex interaction is mediated either by multiple A. phagocytophilum
adhesins or by a single adhesin having multiple binding domains (29, 194). The A.
phagocytophilum adhesin(s) that mediates attachment to human sLex-modified PSGL-1 has
yet to be identified.
A. phagocytophilum undergoes a biphasic developmental cycle, transitioning
between a smaller electron dense-cored cell (DC), which has a dense nucleoid, and a
larger, pleomorphic electron lucent reticulate cell (RC), which has a dispersed nucleoid
(69, 123-125, 140, 151, 185). The respective pathobiological role that each form plays has
not been elucidated, but indirect insights into their potential roles are presented when the
biphasic developmental cycles of other intravacuolar pathogens are considered. Biphasic
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development was first identified and is most well studied for Chlamydia species, but it has
also been observed for two Anaplasmataceae pathogens, Anaplasma marginale (122, 124)
and Ehrlichia chaffeensis (140, 199), as well as Coxiella burnetii, the causative agent of Q
fever (70, 116). Chlamydial elementary bodies (EB), which are analogous to DCs, are
metabolically inert, environmentally resistant, and mediate attachment to and entry of
eukaryotic host cells (3).

Following attachment, EBs are internalized via induced

phagocytosis into a host cell-derived vacuole. EBs remain within the pathogen-occupied
vacuole, where they differentiate into noninfectious, metabolically active reticulate bodies
(RB) and subsequently begin to divide by binary fission. Next, the progeny RB condense
into EB and are released to reinitiate infection.

Zhang and colleagues recently

demonstrated that the E. chaffeensis DCs and RCs play analogous pathobiological roles to
chlamydial EB and RB, respectively (199).
Obligate intracellular pathogen binding to host cells precedes entry and is therefore
requisite for survival.

An important observation that has been made for both the

chlamydial EB and E. chaffeensis DC is that they specifically express outer membrane
proteins that have been identified as adhesin candidates (143, 162, 186, 199), while the RC
forms of each bacterium do not. Because A. phagocytophilum also transitions between the
DC and RC, we hypothesized that adhesins targeting PSGL-1 are expressed on the DC. To
test this hypothesis, we monitored A. phagocytophilum development in human
promyelocytic HL-60 cells over a 72-h time course following synchronous infection and
tested bacterial populations enriched for DCs or RCs for their abilities to adhere to human
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PSGL-1 expressed on transfected Chinese hamster ovary (CHO) cell surfaces and to bind
and infect HL-60 cells.

RESULTS
A. phagocytophilum binding to, invasion of, and replication within HL-60 cells.
To assess which A. phagocytophilum morphological form is responsible for binding
and invasion of host myeloid cells and to monitor the kinetics of bacterial intracellular
replication, differentiation between DC and RC, and reinfection, host cell-free A.
phagocytophilum organisms were added to HL-60 cells.

After removal of unbound

bacteria, aliquots were processed at different time points over 72 h and observed by
transmission electron microscopy. A. phagocytophilum DCs were 0.83 ± 0.24 µm wide,
had a dense nucleoid and a ruffled outer membrane, and were spheroid (Fig. 5A to H and
6). RCs were 0.69 ± 0.36 µm by 1.04 ± 0.44 µm, had dispersed nucleoids and outer
membranes that were somewhat smoother than those observed for DCs, and were
pleomorphic. Representative electron micrographs depicting DCs and RCs are presented
in Figure 5. We occasionally observed individual DCs surrounded by a membranous
projection within inclusions harboring other DCs (Fig. 5A). A similar observation was
reported for Ehrlichia species (140).
At 40 min and 4 h, only DCs were observed binding to, inducing their uptake by, or
residing within host cells. At 40 min, 73.8% (214 of 290) of DCs were bound at the
surfaces of HL-60 cells or inducing their own uptake by HL-60 cells, while only 26.2% (76
of 290) had internalized into host cell-derived vacuoles (Fig. 6A to C). By 4 h, 45.5% (30
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of 55) had internalized (Fig. 6E and F). At 40 min and 4 h, internalized DCs were tightly
associated with the luminal faces of their host cell-derived vacuoles, which were barely
larger than the DCs themselves (Fig. 6C, E, and F).
At 12 h, DCs were no longer associated with host cell surfaces (Fig. 7A). At this
time point, the only DCs that were observed were individual bacteria harbored within
tightly associated vacuoles comparable to those observed at 4 h (data not shown). The
majority of pathogen-occupied vacuoles harbored one to a few RCs and were more
spacious than those harboring DCs. Thus, bacterial replication had initiated and was
concomitant with enlargement of the A. phagocytophilum-occupied vacuole. By 24 h, a
considerable degree of replication had occurred, as evidenced by large vacuoles containing
numerous RCs that were more elongated than the RCs observed at 12 h (Fig. 7B). Some
vacuoles contained A. phagocytophilum organisms that had begun to condense to DCs
(Fig. 7B). By 36 h, multiple inclusions harboring individual DCs or RCs that were tightly
associated with the luminal walls of their vacuoles were once again observed (Fig. 7C and
D), which reflects the occurrence of reinfection by A. phagocytophilum organisms that had
been released between 24 and 36 h.
immunofluorescent

detection

of

This premise is further supported by

extracellular

and

HL-60

surface-bound

A.

phagocytophilum organisms at all post-24-h time points (data not shown). Also at 36 h,
individual host cells contained mature and nascent A. phagocytophilum inclusions (Fig.
7D). Consequently, the infection of the HL-60 culture proceeded asynchronously for the
remainder of the time course. This was apparent in cells observed at 48 h and 72 h, at
which time the host cells were heavily infected with multiple inclusions that harbored
29

Figure 5. A. phagocytophilum DCs and RCs. A. phagocytophilum organisms were
cultivated in HL-60 cells and examined by transmission electron microscopy.
Representative images of DCs (A to H) and RCs (I to P). (A to H) DCs were 0.83 ± 0.24
µm wide, had a dense nucleoid and a ruffled outer membrane, and were spheroid. The
arrow in panel A denotes an individual DC surrounded by a membranous projection. (I to
P) RCs were 0.69 ± 0.36 µm by 1.04 ± 0.44 µm, had a dispersed nucleoid and an outer
membrane that was somewhat smoother than that observed for DCs, and were
pleomorphic. Panels F and N are magnifications of the boxed areas in panels E and M,
respectively. Scale bars, 0.5 µm.
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Figure 6. A. phagocytophilum adhesion to, invasion of, and replication within HL-60
cells. Host cell-free A. phagocytophilum organisms were incubated with HL-60 cells.
After 40 min, unbound bacteria were removed and host cells were examined by
transmission electron microscopy. (A to C) At 40 min, DC organisms were observed
binding to and triggering their own uptake by HL-60 cells. (D to F) At 4 h, some DC
organisms remained bound at the HL-60 cell surface, while others had been internalized
into vacuoles that were in close proximity to the host cell surface. No RC organisms were
observed interacting with HL-60 cell surfaces. Scale bars, 0.5 µm. Representative results
of one of two separate experiments are shown.
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Figure 7. Intracellular development of A. phagocytophilum in HL-60 cells. Host cellfree A. phagocytophilum organisms were incubated with HL-60 cells.

After 40 min,

unbound bacteria were removed and host cells were examined at 12 (A), 24 (B), 36 (C and
D), 48 (E), and 72 h (F) postinfection by transmission electron microscopy. Arrowheads
in panels B and E indicate morulae harboring A. phagocytophilum organisms that are
transitioning from RCs to DCs. Arrows in panels D and F denote inclusions that contain
DCs. Scale bars, 1.0 µm. Representative results of one of two separate experiments are
shown.
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numerous DCs or RCs (Fig. 7E and F). Also observed were inclusions that contained
bacteria that were transitioning from RCs to DCs (Fig. 7E). At no time point was fusion of
morulae observed.
Not all A. phagocytophilum organisms that initially bound to HL-60 cell surfaces
remained attached or successfully entered host cells. At 40 min, 62% of the HL-60 cells
had attached A. phagocytophilum organisms (data not shown). By 4 h, the percentage of
HL-60 cells with bound bacteria had dropped to 29%. By 24 h, approximately 25% of the
cells were infected, which suggests that those organisms that had remained bound at 4 h
successfully invaded.

Quantification of the numbers of A. phagocytophilum organisms observed per morula
and the relative abundance of DC and RC observed over the course of infection.
To better characterize the developmental cycle over the course of infection, the
numbers of A. phagocytophilum DCs or RCs per morula were counted for each time point.
The greatest diversity in the number of bacteria per inclusion was observed at 24 h (Fig.
8A). At 36 h, the largest numbers of vacuoles containing individual DCs or RCs or two
RCs were observed, which signified that reinfection had occurred and the newly
internalized bacteria were transitioning or had recently transitioned into RCs (Fig. 7C and
D and 8A). As a prerequisite step for isolating A. phagocytophilum populations enriched
for DCs or RCs and assessing their differential cellular adherence and recognition of
PSGL-1, we determined the optimal time points for recovering such bacterial populations
by counting the total number of DCs or RCs from all electron micrographs generated from
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Figure 8. Number of A. phagocytophilum organisms observed per morula and the
relative abundances of DCs and RCs observed over the course of infection. Values
presented were determined by enumerating the numbers of A. phagocytophilum organisms
within individual morulae observed by transmission electron microscopy (A) and the total
numbers of RCs and DCs in Fig. 6 and 7 (B). (A) Numbers of organisms observed per
morula between 12 and 72 h postinfection. Morulae containing 1 to 2, 3 to 5, 6 to 10, 11 to
15, and ≥16 organisms were enumerated and are presented as percentages of the total
number of morulae.

(B) Total numbers of DCs and RCs observed binding to or

internalized within HL-60 cells. Representative results of one of two separate experiments
are shown.

37

38

the time course analysis. It is important to keep in mind that the true numbers of DCs or
RCs are underrepresented by this method, as they were determined from two-dimensional
cross-sections of infected cells. The greatest relative abundance of RCs with a minimal
amount of DCs prior to reinfection occurred at 24 h (Fig. 8B). Though RCs outnumbered
DCs at all postreplication time points, the greatest number of DCs was observed at 72 h.

DC-enriched A. phagocytophilum organisms bind and infect HL-60 cells more
effectively than RC-enriched bacteria.
Our electron microscopy time course studies revealed that DC, but not RC,
organisms bound and were internalized into HL-60 cells (Fig. 6 to 8). We therefore
rationalized that the A. phagocytophilum DC is more effective than the RC at adhering to
and invading host cells.

To assess this, we isolated DC- and RC-enriched A.

phagocytophilum populations from infected HL-60 cells.

Following a synchronous

infection, host cell-free A. phagocytophilum populations were recovered at 24 and 72 h,
visualized by electron microscopy, and enumerated.

A. phagocytophilum populations

isolated at 24 h consisted of 70.1% ± 3.4% RCs and 29.9% ± 3.4% DCs (Table 1). At 72
h, 53% more DC organisms were present, as host cell-free bacterial populations contained
45.8% ± 14.7% DCs.

Accordingly, A. phagocytophilum populations recovered from

infected HL-60 cells at 24 h and 72 h are denoted as RC- and DC-enriched populations,
respectively. Next, comparable amounts of DC- and RC-enriched A. phagocytophilum
organisms were isolated and incubated with naïve HL-60 cells. After the removal of
unbound organisms, the numbers of adhered bacteria or morulae per cell were determined.
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Table 1. Quantification of A. phagocytophilum RCs and DCs
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Figure 9.

Binding and infection of RC- and DC-enriched A. phagocytophilum

organisms in HL-60 cells. Comparable amounts of host cell-free A. phagocytophilum
organisms were isolated at 24 h (RC-enriched) or 72 h (DC-enriched) following a
synchronous infection and incubated with naïve HL-60 cells for 40 min.

(A) After

removal of unbound bacteria, aliquots were examined by indirect immunofluorescence
microscopy and the mean numbers of bound A. phagocytophilum organisms per cell were
enumerated. (B) The remainders of each infected HL-60 culture were grown for 96 h,
during which aliquots were removed at 24-h intervals and assessed for infection, as
determined by light microscopic detection of morulae. Results shown are the means of
four separate experiments. Statistically significant values are indicated (*, P < 0.05).
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Significantly more DC-enriched organisms bound to HL-60 cells than RC-enriched
bacteria (Fig. 9A). Likewise, significantly more morulae were observed at 72 and 96 h
postinfection within HL-60 cells that had been incubated with DC-enriched bacteria than
cells that had been incubated with RC-enriched organisms (Fig. 9B).

A. phagocytophilum DC-enriched organisms more effectively bind PSGL-1 CHO cells
than RC-enriched organisms.
Because significantly more binding to and infection of HL-60 cells were observed
for DC-enriched A. phagocytophilum organisms than RC- enriched bacteria and because
susceptibility of human neutrophils and HL-60 cells to A. phagocytophilum binding and
infection is directly attributable to surface expression of PSGL-1 (58, 74, 144), we next
compared the abilities of comparable amounts of DC- and RC-enriched organisms to bind
to the surfaces of PSGL-1 CHO cells (100, 192). In addition to PSGL-1, these cells
coexpress α1,3-fucosyltransferase VII and core 2 β1,6-N-acetylgluocsaminyltransferase,
which are required to glycosylate PSGL-1 such that it is decorated with sLex, binds to Pselectin, and supports A. phagocytophilum binding (29, 74, 100, 194). Flow cytometry
analyses confirmed that PSGL-1 CHO cells express PSGL-1 and sLex on their cell surfaces
(Fig. 10A and B). Significantly more DC-enriched A. phagocytophilum organisms than
RC-enriched bacteria bound to PSGL-1 CHO cells in the presence of isotype control
antibody (Fig. 11).

Monoclonal antibody (MAb) KPL1, which interferes with A.

phagocytophilum binding by blocking access to the PSGL-1 N-terminal peptide
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Figure 10.

Analysis of PSGL-1 CHO and CHO (‒) cells for PSGL-1 and sLex

expression. PSGL-1 CHO and CHO (‒) cells were incubated with anti-PSGL-1 MAb
KPL-1 (A), anti-sLex MAb CSLEX1 (B), or isotype-matched controls. Alexa Fluor 488conjugated secondary antibodies detected bound primary antibodies.
results of one of two separate experiments are shown.
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Representative
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Figure 11.

Binding of RC- and DC-enriched A. phagocytophilum organisms to

PSGL-1 CHO and CHO (‒) cells.

Comparable amounts of host cell-free A.

phagocytophilum organisms isolated at 24 h (RC-enriched) and 72 h (DC-enriched) postsynchronous infection were incubated with PSGL-1 CHO cells in the presence of antiPSGL-1 MAb KPL-1 or isotype control or with CHO (‒) cells. After removal of unbound
bacteria, A. phagocytophilum binding was assessed by indirect immunofluorescence
microscopy.

Representative results of one of three separate experiments are shown.

Statistically significant values are indicated (**, P < 0.01; ***, P < 0.001).
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(74, 144, 145, 160), reduced binding by DC- and RC-enriched populations to PSGL-1
CHO cells to the background binding levels observed for CHO (‒) cells.

Confirmation that the A. phagocytophilum DC specifically recognizes PSGL-1.
Because DC-enriched organisms bound most effectively to HL-60 cells and PSGL1 CHO cells relative to RC-enriched bacteria (Fig. 9 and 11), we hypothesized that the A.
phagocytophilum DC specifically recognizes PSGL-1 while the RC does not. Because
RC-enriched bacteria more effectively bound to PSGL-1 CHO cells than to CHO (‒) cells
in the presence of isotype control antibody (Fig. 11), we further hypothesized that the
contaminating DC in the RC-enriched population mediated PSGL-1 recognition. To verify
this, PSGL-1 CHO cells were incubated with comparable amounts of DC- or RC-enriched
A. phagocytophilum populations and visualized by transmission electron microscopy. For
both populations, ≥91.5% ± 3.5% of the A. phagocytophilum organisms that bound to the
surfaces of PSGL-1 CHO cells were the DC form (Fig. 12A, B, and D). The few non-DC
forms attached to PSGL-1 CHO surfaces did not resemble RCs. Instead, they resembled
either bacterial membrane ghosts (Fig. 12C) or what appeared to be transitional forms that
were intermediate in size relative to DCs and RCs and exhibited outer membranes that
were more ruffled than the RC, but not as ruffled as the DC (Fig. 12E). These results
support that the DC is the A. phagocytophilum morphological form that mediates binding
to PSGL-1 and indicate that late-stage transition organisms are also capable of binding
PSGL-1.
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Figure 12.

A. phagocytophilum DCs, but not RCs, bind to PSGL-1 CHO cells.

Comparable amounts of host cell-free DC-enriched or RC-enriched populations were
incubated with PSGL-1 CHO cells. After removal of unbound bacteria, the PSGL-1 CHO
cells were examined by transmission electron microscopy. (A) Percentage of bound A.
phagocytophilum organisms that are in either the DC stage or other (membrane ghosts or
transition) stages that were observed bound to the surfaces of PSGL-1 CHO cells. One
hundred PSGL-1 CHO cell-associated A. phagocytophilum organisms were counted per
population per experiment. Scale bars, 0.5 µm. Results shown are the means of two
separate experiments. Statistically significant values are indicated (**, P < 0.01; ***, P <
0.001). (B to E) Representative transmission electron micrographs showing a DC (B and
D), a membrane ghost (C), or a putative transition stage organism (E) interacting with the
PSGL-1 CHO cell surface.
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DISCUSSION
Our data demonstrate that the A. phagocytophilum DC mediates cellular adhesion,
recognizes human PSGL-1, and invades human myeloid cells, while the RC does not. In
the hundreds of transmission electron micrographs of HL-60 or PSGL-1 CHO cells with
bound or newly internalized A. phagocytophilum examined, DCs were almost always
observed interacting with the host cell surfaces or within nascent inclusions. We never
observed RCs attached to host cell surfaces or within nascent vacuoles.

Similar

observations have been reported for A. phagocytophilum and E. chaffeensis interactions
with ISE6 tick embryonic cells and DH82 histiocytoma cells, respectively (123, 199). In
rare instances, we observed membrane ghosts or what appeared to be late-transition stage
organisms exhibiting characteristics of both DC and RC binding to host cell surfaces. The
latter observation is not surprising given that A. phagocytophilum differentiation is a
continual process and syringe lysis of infected cells would conceivably release DC, RC,
and transition stage organisms for subsequent incubation with host cells. The abilities of
DC and transition stage organisms and the inability of RC to bind to human PSGL-1
presented on eukaryotic cell surfaces hints that expression and/or posttranslational
modification of the adhesin(s) requisite for PSGL-1 recognition occurs during A.
phagocytophilum differentiation from RC to DC. This expression pattern is analogous to
that for putative adhesins of other obligate vacuolar pathogens that exhibit biphasic
development, such as E. chaffeensis, C. trachomatis, and C. pneumoniae (143, 162, 164,
186, 199).
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The percentage of HL-60 cells with bound A. phagocytophilum organisms declined
from 62% at 40 min to 29% at 4 h, which suggests that not all A. phagocytophilum DC or
late transition stage organisms that initially bind to the host cell surfaces are capable of
remaining bound. Also, A. phagocytophilum entry into human myeloid cells in vitro is
variable and can take hours. Indeed, we observed that only 26.2% of DCs had entered HL60 cells by 40 min, while 73.8% remained surface bound. By 4 h, 45.5% of the DCs had
entered. Using fluoresceinated bacteria, we and others have previously shown that it takes
up to 4 h for an appreciable number of bound A. phagocytophilum organisms to invade
HL-60 cells or neutrophils (23, 28, 83).

We surmise that inefficient binding and/or

invasion is related to suboptimal expression or posttranslational modification of adhesins
or other virulence factors that are requisite for adhesion and/or entry by bacteria that have
not yet fully differentiated into infectious DC. AnkA, a type IV secretion system effector,
is delivered into HL-60 cells within minutes following A. phagocytophilum binding (81,
101) We observed newly internalized DCs remaining tightly associated with the inner face
of the inclusion membrane during initial postinvasion hours.

This may allow A.

phagocytophilum to continue to deliver AnkA and/or other type IV effectors into the host
cell cytosol following entry.
HL-60 cells are nonphagocytic (26, 135), yet we observed HL-60 plasma
membrane extensions engulfing bound organisms, which indicates that cytoskeletal
rearrangement is evoked upon A. phagocytophilum binding, presumably to PSGL-1. Our
visualization of this process is in agreement with published electron micrographs depicting
A. phagocytophilum invasion of ISE6 cells and E. chaffeensis invasion of DH82 cells (123,
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199) but contradicts the supposition that the bacterium enters via receptor-mediated
endocytosis, not phagocytosis (103, 195). PSGL-1 is a signaling molecule in leukocytes
(178). A. phagocytophilum engagement of PSGL-1 activates the tyrosine kinase, Syk, a
step that is essential for PSGL-1-dependent entry (145, 171, 178). PSGL-1 is present and
interacts with Syk in lipid rafts at the myeloid cell surface (2). PSGL-1 association with
Syk is mediated through ezrin and moesin (6, 178), which also function as membrane-actin
cytoskeleton linkers and play roles in the formation of protrusive membrane structures
such as filopodia and membrane ruffles (87). Thus, we propose that A. phagocytophilum
binding of PSGL-1 promotes actin cytoskeletal rearrangement through Syk-ezrin/moesinmediated signaling, which culminates in induced phagocytic- rather than endocyticbacterial uptake. Further support for our premise comes from observations that treatment
with methyl-β cyclodextrin, which disrupts lipid rafts by chelating cholesterol (66),
prevents Syk recruitment to interact with PSGL-1 (2) and prevents A. phagocytophilum
entry (103).
Our data demonstrate that A. phagocytophilum RCs are the replicative form. At 4
h, individual DCs were observed within nascent inclusions.

By 12 h, individual or

multiple RCs were present within inclusions, thereby signifying that replication had
initiated.

The A. phagocytophilum genome codes for ftsZ (APH_1292) (96), which

suggests that replication occurs by binary fission. By 24 h, the number of RCs within
morulae had increased considerably.

During this burst of replication, the morula

membrane increases in size, which partially accommodates the large numbers of RCs it
harbors. However, intravacuolar space does become limited. Indeed, RCs within mature
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inclusions harboring large bacterial numbers are more elongated than the individual or few
spheroid RCs within nascent vacuoles, perhaps as a means of conforming to the available
intravacuolar space.
A. phagocytophilum development within HL-60 cells is asynchronous. By 24 h,
condensation of RC into DC has initiated within some, but not all, morulae.

After

replication to a considerable number of RCs within individual morulae, A.
phagocytophilum organisms condense into DCs and are subsequently released in a timely
manner to initiate new infections. This premise is supported by observations that multiple
vacuoles harboring individual organisms were once again observed at 36 h and that RCs
outnumbered DCs at all time points after RCs were first observed.

Whether these

developmental kinetics are reminiscent of the development within neutrophils and whether
A. phagocytophilum DCs are released from host cells in a lytic or nonlytic fashion remain
to be confirmed.
A. phagocytophilum development within individual morulae within HL-60 cells is
highly synchronous, an observation that is consistent with that of A. phagocytophilum
development within ISE6 cells and E. chaffeensis development within DH82 cells (123,
199). Interestingly, the chlamydial developmental cycle within inclusions is asynchronous
(3). Thus, these two obligate intravacuolar bacterial pathogens, each of which undergoes
biphasic development, are prompted by distinct signals to transition from DC (or EB) to
RC (or RB). It has been proposed that chlamydial RB detachment from the vacuolar face
of the inclusion membrane caused by overcrowding within the inclusion provides the
signal for RB to condense to EB (76).
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Such a model does not apply to A.

phagocytophilum. Rather, the synchronous development of A. phagocytophilum within
inclusions suggests that the entire intravacuolar population simultaneously receives signals
that prompt differentiation. Also in contrast to what has been observed for Chlamydia
species (3) is that we never observed fusion between morulae. Even as HL-60 cells
became heavily infected, morulae in direct contact with each other remained distinct. This
is in agreement with our previous observation that independent morulae containing
transgenic A. phagocytophilum organisms expressing either green fluorescent protein or
mCherry within the same HL-60 cell do not fuse (145).
A. phagocytophilum organisms isolated at 72 h bind more effectively to and yield
more productive infections of HL-60 cells than bacteria isolated at 24 h. This is due to the
presence of more adherence-competent and infectious DC organisms being present at 72 h
than at 24 h. Nevertheless, the mean standard deviations of bound organisms per cell and
the percentages of infected HL-60 cells were considerably greater for DC-enriched
populations (Fig. 9). We attribute this to the fact that at 24 h, the relative amounts of RCs
and DCs were consistent for each of the three A. phagocytophilum populations isolated and
used as inocula, while the RC-to-DC ratio varied among the three inoculum populations
isolated at 72 h (Table 1). The variability at 72 h is a result of asynchronous development
occurring later in infection. The marginal binding of A. phagocytophilum organisms of
RC-enriched populations to HL-60 and PSGL-1 CHO cells is due to the contaminating
DC, a premise that is supported by the fact that electron microscopy detected only DC
binding to PSGL-1 CHO cells following incubation with RC-enriched populations.
Neoexpression of fucosylated PSGL-1 in CHO cells is an effective model for
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studying A. phagocytophilum interactions with PSGL-1. Intriguingly, we never observed
morulae within PSGL-1 CHO cells even at 24 h postinfection (data not shown). This is in
striking contrast to the ability of the bacterium to not only bind but also to enter and
replicate within B lymphoblastoid BJAB cells transfected to express fucosylated PSGL-1
(74) and hints that certain host cell factors and/or signaling platforms may be required to
optimally support A. phagocytophilum.
In closing, the respective roles of the A. phagocytophilum DCs and RCs are
adherence/infection and vacuolar replication, an observation that is consistent with the life
cycles of other obligate intravacuolar pathogens that undergo biphasic development.
Moreover, the A. phagocytophilum DC is responsible for recognizing PSGL-1, the
dominant receptor for infection of human myeloid cells. Future characterization of the DC
surface proteome will be vital to identifying the adhesin(s) that mediate PSGL-1
recognition. Deciphering the adherence mechanism by which A. phagocytophilum engages
PSGL-1 as a prerequisite for host cell entry will characterize a vital step in A.
phagocytophilum pathogenesis and potentially lead to the development of novel,
nonantibiotic-based approaches for treating or preventing HGA.

METHODS
Cultivation of A. phagocytophilum and CHO cells. A. phagocytophilum strains HZ and
NCH-1 were cultured in HL-60 cells (28). HZ was a gift from both Ralph Horwitz of New
York Medical College (Valhalla, NY) and Yasuko Rikihisa of The Ohio State University
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(Columbus, OH).

Untransfected CHO cells [CHO(‒)] and transfected CHO cells

coexpressing human PSGL-1, α1,3-fucosyltransferase VII, and core 2 β1,6-N
acetylglucosaminyltransferase (PSGL-1 CHO) were gifts from Rodger McEver (Oklahoma
Medical Research Foundation) and were maintained as described previously (100).

Assessment of A. phagocytophilum binding to, invasion of, and intracellular
development in HL-60 cells by electron microscopy. Host cell-free A. phagocytophilum
organisms were recovered from twice the number of infected HL-60 cells and added to
naïve HL-60 cells to initiate a synchronous infection. Aliquots (8.0 x 106 cells) were
removed at 0.7, 4, 12, 24, 36, 48, and 72 h. The A. phagocytophilum-infected HL-60 cells
were washed once in 0.1 N Sorenson phosphate buffer (SPB), pH 7.4, to remove any
media and immediately fixed in 3.5% glutaraldehyde made in 0.1 N SPB for 1 h. Samples
were subjected to four 15-min washes in 0.1 N SPB with 4% sucrose and stained with 1%
OsO4 in 0.1 N SPB for 1 h at 4 degrees Celsius (°C). Samples were washed five times in
0.1 N SPB with 4% sucrose for 3 min each, followed by dehydration in a graded series of
50, 70, 80, 90, and 100% ethanol for 5 min each. Next, propylene oxide (PO) was used to
wash each sample twice for 5 min each, after which a 1:1 mixture of PO and LX-112 resin
mixture was added.

Resin mixture consisted of dodecenyl succinic anhydride, nadic

methyl anhydride, LX-112 resin, and 2,4,6-tri(dimethylaminomethyl) phenol (Ladd
Research, Williston, VT). Samples were left overnight under a heat lamp. The next day,
the PO-LX-112 resin mixture was removed and the samples were incubated in LX-112
resin mixture for 5 h under a heat lamp. Samples were centrifuged, the resin mixture was
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removed, fresh resin was added, and samples were allowed to harden at 60°C for 48 h.
Samples were thin sectioned on a Reichert Jung Ultracut E microtome, poststained with
uranyl acetate, and examined in a Tecnai BioTWIN 12 (Philips, Hillsboro, OR) or JEM1230 (JEOL, Tokyo, Japan) transmission electron microscope.

Preparation of RC- and DC-enriched populations of A. phagocytophilum. RC- or DC
enriched populations of A. phagocytophilum organisms were prepared as follows. Bacteria
were liberated from infected (≥90%) HL-60 cells by syringe lysis, followed by differential
centrifugation to separate bacteria from host cell debris (27). We empirically determined
that an infection seeded from bacteria obtained from 10 times the number of infected cells
that proceeds for 24 h yields a bacterial load that is comparable to an infection seeded from
two times the number of infected cells that proceeds for 72 h. Accordingly, host cell-free
bacteria obtained from 10 or 2 times the number of infected cells were added to uninfected
cells to establish synchronous infections that proceeded for 24 or 72 h, respectively. To
allow for bacterial adherence, A. phagocytophilum organisms were incubated with 2.0 x
106 HL-60 cells in 1 milliliter (ml) of Iscove’s modified Dulbecco’s Eagle medium
(IMDM) (Invitrogen, Carlsbad, CA) supplemented with 10% fetal bovine serum (FBS)
(IMDM-10).

Host cells were sedimented at 300 x g for 5 min, washed twice with

phosphate-buffered saline (PBS) to remove unbound bacteria, and incubated at 37°C in 5%
carbon dioxide (CO2). To quantify the percentages of A. phagocytophilum host cell-free
RC- and DC-enriched organisms at 24 and 72 h, respectively, the infected host cells were
syringe lysed and the bacteria were recovered by differential centrifugation and processed
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for electron microscopy as described above. Multiple sections for each sample were
viewed, and several hundreds to thousands of individual RCs and DCs were counted.

Assessment of binding to and infection of HL-60 cells by RC- and DC-enriched
populations of A. phagocytophilum using immunofluorescence microscopy and light
microscopy. DC- or RC-enriched populations of A. phagocytophilum organisms were
prepared as described above. At 24 or 72 h, RC- or DC-enriched A. phagocytophilum
populations, respectively, were recovered from two times the number of infected cells and
added to naïve HL-60 cells to establish a second synchronous infection, which was
assessed for bacterial binding by immunofluorescence microscopy.

Samples were

monitored for infection by using light microscopic examination of samples that had been
centrifuged onto glass slides using a Shandon Cytospin 4 cytocentrifuge (Thermo
Scientific, Waltham, MA) at 24, 48, 72, and 96 h postinfection as described previously
(27).

Measurement of PSGL-1 and sLex expression of CHO cells by flow cytometry. CHO
cells

were

removed

from

adherent

flasks

with

0.5

millimolar

(mM)

ethylenediaminetetraacetic acid (EDTA) (Irvine Scientific, Santa Ana, CA). Cells were
treated with Fc block (5µg/ml) (BD Pharmingen, San Diego, CA) for 5 min, followed by
incubation with CSLEX (binds to sLex) (BD Pharmingen) (51), KPL1 (binds to the human
PSGL-1 N terminus) (BD Pharmingen) (160), or murine immunoglobulin G1 (IgG1) or
murine IgM isotype control antibodies (5 µg/ml). Following 30 min on ice, the cells were
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washed twice with PBS. Alexa Fluor 488-conjugated goat secondary antibody against
either mouse IgM or IgG (Invitrogen) was added to a final concentration of 5 µg/ml. After
30 min on ice, the cells were washed with PBS, fixed with 1% PFA, and analyzed on a BD
Biosciences FACScan using CellQuest Pro software (BD Pharmingen).

Assessment of A. phagocytophilum binding to CHO cells by immunofluorescence
microscopy. PSGL-1 CHO or CHO (‒) cells were grown on 12-mm diameter round
coverslips (Electron Microscopy Sciences, Hatfield, PA) in 24-well tissue culture plates
(Greiner Bio-One, Monroe, NC) to near-confluent monolayers. The cells were washed
twice with PBS. PSGL-1 CHO cells were pretreated with KPL-1 or mouse IgG1 at 10
µg/ml for 30 min on ice. Next, comparable amounts of RC-enriched (isolated 24 h postsynchronous infection as described above) or DC-enriched (isolated 72 h post-synchronous
infection) A. phagocytophilum organisms were added at an approximate ratio, using host
cell-free organisms liberated from twice the number of infected HL-60 cells as naïve CHO
cells. Following a 30-min incubation at 25°C with rocking, the cells were washed three
times with PBS to remove unbound organisms. Cells were fixed with methanol, and
bound organisms were detected by immunofluorescence microscopy and enumerated (27).

Assessment of binding of DC- or RC-enriched A. phagocytophilum organisms to CHO
cells using electron microscopy. Comparable amounts of DC- or RC-enriched host cellfree bacterial populations were liberated from 10 times the number of infected HL-60 cells
and added to naïve CHO cells. Bacteria and CHO cells were incubated at a concentration
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of 2.0 x 106 CHO cells in 1 ml of PBS for 30 min at 25°C. The cells were centrifuged at
300 x g and washed twice with PBS to remove unbound bacteria and processed for
electron microscopy as described above.

Statistical analyses. Student’s (paired) t test performed using the Prism 4.0 software
package (GraphPad, San Diego, CA) was used to assess statistical significance. Statistical
significance was set at a P value of <0.05.
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CHAPTER 3: In Silico Identification of A. phagocytophilum
Outer Membrane Proteins

INTRODUCTION
Having established that the A. phagocytophilum DC is responsible for binding
human sLex-modified PSGL-1 and the adhesin(s) are likely surface exposed proteins, the
next approach was to predict how many outer membrane proteins (OMPs) may be
encoded. In 2006, the complete genome of A. phagocytophilum (strain HZ) was sequenced
and annotated (45). Sequence analysis identified several important observations about
membrane structure. It revealed that, although classified as a gram-negative organism by
gram stain, A. phagocytophilum has lost all genes for Lipid A synthesis and lacks most of
the genes for peptidoglycan synthesis (45, 102). As a means to potentially compensate for
the loss of Lipid A, host cell cholesterol is inserted in the membrane (193). Sequence
analysis also noted A. phagocytophilum does not encode any pili or capsules (45), so all
OMPs are most likely afimbrial integral membrane proteins.
To generate a list of putative surface proteins, we sought to analyze the A.
phagocytophilum genome by computer programs.

There are a variety of prediction

programs available and some even claim to have a lower error of prediction rate than
experimental laboratory approaches (147). To obtain an approximate number of how
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many A. phagocytophilum OMPs may be encoded, we compared 2 computer prediction
program results to those predicted when the genome was sequenced.

RESULTS
TIGR predicted OMPs.
The Institute of Genomic Research (TIGR) sequenced A. phagocytophilum (strain
HZ) (45), which was annotated and divided into 25 gene role categories. A total of 43 cell
envelope proteins were predicted by TIGR and is listed in Table 2. Due to the large
number of Msp2(P44) paralogs and its known surface localization, it was excluded from
all computer analysis.

CELLO and PSORTb predicted OMPs.
The A. phagocytophilum genome was analyzed by the subCELlular LOcalization
predictor program (CELLO) (196) and PSORTb (197) to predict potential OMPs. CELLO
confidently identified 65 OMPs as well as 65 proteins that could localize to the outer
membrane and elsewhere.

In total, CELLO predicted up to 130 proteins that could

potentially function as OMPs (Table 3). PSORTb was more conservative in analysis as it
only predicted 16 OMPs (Table 4).

DISCUSSION
When results of the different computer prediction programs were compared, the
data revealed there were discrepancies and similarities between predictions.
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When

Table 2. TIGR predicted Ap OMPs
Predicted Cellular
Ap protein
Location
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43

APH_0094
APH_0221
APH_0234
APH_0338
APH_0382
APH_0383
APH_0385
APH_0386
APH_0387
APH_0449
APH_0452
APH_0453
APH_0454
APH_0455
APH_0457
APH_0510
APH_0540
APH_0541
APH_0594
APH_0611
APH_0612
APH_0625
APH_0728
APH_0878
APH_0919
APH_0922
APH_0924
APH_0949
APH_0985
APH_0995
APH_1017
APH_1049
APH_1210
APH_1219
APH_1220
APH_1240
APH_1250
APH_1325
APH_1345
APH_1358
APH_1359
APH_1361
APH_1387

Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
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Table 3. CELLO predicted Ap OMPs
Ap protein
Predicted Cellular Location
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45

APH_0015
APH_0018
APH_0023
APH_0035
APH_0043
APH_0050
APH_0051
APH_0068
APH_0081
APH_0110
APH_0117
APH_0221
APH_0328
APH_0376
APH_0392
APH_0404
APH_0405
APH_0406
APH_0469
APH_0506
APH_0537
APH_0582
APH_0597
APH_0614
APH_0634
APH_0683
APH_0705
APH_0707
APH_0708
APH_0716
APH_0723
APH_0755
APH_0805
APH_0807
APH_0808
APH_0811
APH_0838
APH_0839
APH_0849
APH_0861
APH_0874
APH_0905
APH_0906
APH_0976
APH_1013

Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
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46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92

APH_1014
APH_1037
APH_1050
APH_1069
APH_1117
APH_1127
APH_1153
APH_1170
APH_1210
APH_1219
APH_1220
APH_1240
APH_1310
APH_1348
APH_1358
APH_1359
APH_1361
APH_1378
APH_1404
APH_1406
APH_0112
APH_0331
APH_0377
APH_0385
APH_0390
APH_0420
APH_0421
APH_0465
APH_0503
APH_0504
APH_0625
APH_0673
APH_0761
APH_0832
APH_0847
APH_0852
APH_0897
APH_0928
APH_0933
APH_0997
APH_1148
APH_1158
APH_1233
APH_1270
APH_1303
APH_1320
APH_1322

Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer
Outer / Cytoplasmic
Outer / Cytoplasmic
Outer / Cytoplasmic
Outer / Cytoplasmic
Outer / Cytoplasmic
Outer / Cytoplasmic
Outer / Cytoplasmic
Outer / Cytoplasmic
Outer / Cytoplasmic
Outer / Cytoplasmic
Outer / Cytoplasmic
Outer / Cytoplasmic
Outer / Cytoplasmic
Outer / Cytoplasmic
Outer / Cytoplasmic
Outer / Cytoplasmic
Outer / Cytoplasmic
Outer / Cytoplasmic
Outer / Cytoplasmic
Outer / Cytoplasmic
Outer / Cytoplasmic
Outer / Cytoplasmic
Outer / Cytoplasmic
Outer / Cytoplasmic
Outer / Cytoplasmic
Outer / Cytoplasmic
Outer / Cytoplasmic
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93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130

APH_1325
APH_1346
APH_0314
APH_0514
APH_0709
APH_0829
APH_0876
APH_1120
APH_0473
APH_0198
APH_0916
APH_0944
APH_1110
APH_0045
APH_0104
APH_0311
APH_0985
APH_1049
APH_1107
APH_1246
APH_1412
APH_0032
APH_0049
APH_0378
APH_0387
APH_0546
APH_0688
APH_0941
APH_0206
APH_0256
APH_0386
APH_0430
APH_0918
APH_0740
APH_1015
APH_1090
APH_1150
APH_1384

Outer = Outer Membrane

Outer / Cytoplasmic
Outer / Cytoplasmic
Outer / Cytoplasmic / Extracellular
Outer / Cytoplasmic / Extracellular
Outer / Cytoplasmic / Extracellular
Outer / Cytoplasmic / Extracellular
Outer / Cytoplasmic / Extracellular
Outer / Cytoplasmic / Extracellular
Outer / Cytoplasmic / Extracellular / Periplasmic
Outer / Cytoplasmic / Inner
Outer / Cytoplasmic / Inner
Outer / Cytoplasmic / Inner
Outer / Cytoplasmic / Inner
Outer / Cytoplasmic / Periplasmic
Outer / Cytoplasmic / Periplasmic
Outer / Cytoplasmic / Periplasmic
Outer / Cytoplasmic / Periplasmic
Outer / Cytoplasmic / Periplasmic
Outer / Cytoplasmic / Periplasmic
Outer / Cytoplasmic / Periplasmic
Outer / Cytoplasmic / Periplasmic
Outer / Extracellular
Outer / Extracellular
Outer / Extracellular
Outer / Extracellular
Outer / Extracellular
Outer / Extracellular
Outer / Extracellular
Outer / Inner
Outer / Inner
Outer / Inner
Outer / Inner
Outer / Inner
Outer / Periplasmic
Outer / Periplasmic
Outer / Periplasmic
Outer / Periplasmic
Outer / Periplasmic
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Table 4. PSORTb predicted Ap OMPs
Predicted Cellular
Ap protein
Location
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16

APH_0043
APH_0068
APH_0338
APH_0377
APH_0404
APH_0405
APH_0406
APH_0506
APH_0709
APH_0906
APH_1087
APH_1110
APH_1210
APH_1240
APH_1359
APH_1361

Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
Outer Membrane
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comparing the TIGR predicted OMPs to those of CELLO, only 15 proteins were shared.
They were APH_0221, 0385, 0386, 0387, 0625, 0985, 1049, 1210, 1219, 1220, 1240,
1325, 1358, 1359 and 1361. Only 5 of the TIGR proteins (APH_0338, 1210, 1240, 1359
and 1361) were identified by PSORTb. A total of 4 proteins (APH_1210, 1240, 1359 and
1361) were identified by all 3 computer programs. All but 2 proteins (APH_0338 and
1087) identified by PSORTb were also identified by CELLO, indicating PSORTb is
stricter in its predictions. CELLO and PSORTb, but not TIGR was able to predict the
confirmed surface proteins APH_0405 (Asp55) and APH_0404 (Asp62). All programs
also predicted the dominant OMP, Msp2(P44) (data not shown).
The validity of the computer programs is partially validated by the Yan Ge and
Yasuko Rikihisa's surface biotinylation study of A. phagocytophilum (55). They identified
14 proteins, 7 of which were predicted by the computer programs.

Three proteins

(APH_1210, 1359 and Msp2[P44]) were predicted by all 3 computer programs. The two
confirmed OMPs (APH_0405 [Asp55] and 0404 [Asp62]) were predicted by CELLO and
PSORTb. The final two proteins (APH_1170 and 1406) were only predicted by CELLO.
This is reminiscent of a study of Helicobacter pylori in which biotinylation experimentally
identified 18 OMPs, and only 2 were predicted as surface proteins (153).
One limitation of prediction programs for our purposes is that it still does not
determine whether or not the OMP is specifically expressed on the DC, RC or both
developmental forms. As demonstrated in Chapter 2, the adhesin(s) are upregulated or
posttranslationally modified on the adherent/infectious DC form. Therefore, our goal is to
only pursue OMPs on the DC.

A further concern is that other organisms, such as
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Chlamydia, that also lack peptidoglycan and undergo biphasic development, stabilize the
infectious EB's outer membrane by forming numerous disulfide bonds with two cysteinerich proteins (47, 67). This results in the environmentally resistant and stable infectious
Chlamydial EB that can survive harsh treatments with detergents and even sonication,
whereas the fragile non-cross-linked chlamydial replicative RB is destroyed by these
treatments (68, 156, 167). The two cysteine-rich proteins responsible for stability are
believed to be located in the inner leaflet of the outer membrane and periplasmic space.
Their inter- and intra-molecular bonds has made their solubility properties variable,
depending on the treatment used for isolation (47), representing the overall complexity and
unusualness of the Chlamydial membrane.

A. phagocytophilum likely uses a similar

strategy for stability as the infectious DC form can remain structurally intact even after
several minutes of sonication. This property of the infectious A. phagocytophilum DC is
discussed in further detail in Chapter 5.

Although unknown at this time, if A.

phagocytophilum also were to stabilize the DC by disulfide bonds or other unknown
mechanisms, it could potentially stabilize proteins in the outer membrane that do not
possess typical membrane features. If this were true, computer prediction programs may
not identify such proteins as they typically classify proteins based on structural features.
Although computer predictions can serve as a valuable resource, their use in
predicting OMPs of A. phagocytophilum may be limiting. The inconsistency of prediction
between programs, the uniqueness of the membrane (lack of Lipid A and peptidoglycan,
and the DC's resistance to sonication), and the fact experimentally identified OMPs of
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other pathogens (153) were not predicted correctly, suggests some A. phagocytophilum
OMPs will also need to be verified by experimentation in addition to predictions.
Having the sequenced genome is a crucial step forward in the understanding of any
pathogen. Nevertheless, there are even more restrictions when applying this data directly
towards the study of A. phagocytophilum. One of the biggest limitations of working with
A. phagocytophilum, as well as any obligate intracellular pathogen is direct genetic
manipulation of the organism. At this time, site-specific knockouts of genes are not a
possibility. A transposase system has been successfully utilized to insert GFP randomly
into the A. phagocytophilum chromosome (50), suggesting promise for better genetic tools
in the future. Even if genetic manipulations were possible, the small genome of 1.47 Mb
suggests that many genes may be essential for obligate intracellular survival.

If an

essential gene of A. phagocytophilum such as an adhesin was disrupted, the mutant would
not survive and could not be isolated for validation or characterization as it could not be
isolated and grown under any other conditions.
Since direct genetic manipulation of A. phagocytophilum is not an option for
experimentation, it means that any putative surface protein/adhesin will have to be tested
by traditional methods.

This will entail expressing a protein in recombinant form,

generating antiserum, and testing the antiserum to confirm expression and localization of
the protein to the outer membrane. Regardless, computer predictions are still valuable
data, therefore other members of the Carlyon lab have compared these lists to other
experimental data (55, 128) and are working on expressing some of the predicted proteins
of interest. Because it is impractical to express great numbers of potential membrane
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proteins in recombinant form, as these are still just predictions, the focus of my dissertation
project was to test other approaches to directly identify OMPs as potential adhesins of A.
phagocytophilum.

METHODS
TIGR predicted cell envelope genes of unknown function. A. phagocytophilum (strain
HZ) genome (45) is divided into 25 gene role categories (http://cmr.jcvi.org/cgibin/CMR/shared/GetNumAndPercentGenesInARole.cgi).

The cell envelope category

consists of 163 (11.9% of the genome) proteins. All 43 proteins (excluding the Msp2[P44]
paralogs) of unknown function in the sub role of "other" were selected for analysis.

CELLO and PSORTb outer membrane protein computer prediction programs. The
entire

Ap

genome

in

the

protein

FASTA

format

(http://www.ncbi.nlm.

nih.gov/sites/entrez?db=genome&cmd=Retrieve&dopt=Protein+Table&list_uids=19215
Display: protein FASTA) was copied and pasted into CELLO program v2.5:
(http://cello.life.nctu.edu.tw/) (196).

Gram-negative organisms and protein sequences

parameters were selected and submitted. All potential OMPs were listed. CELLO is a
multi-class support vector machine classification system. Support vector machines are
learning-based classifiers trained to classify proteins as belonging to a specific localization
site. CELLO uses a single module, based on multiple feature vectors that analyze npeptide compositions to predict the subcellular localization for Gram-negative bacteria.
CELLO analyzes 4 types of sequence coding schemes; the amino acid composition, the di72

peptide composition, the partitioned amino acid composition and the sequence composition
based on the physico-chemical properties of amino acids. Scores from these classifications
determine the proteins final location.
The program PSORTb v3.0 (http://www.psort.org/) (197) was used to analyze the
Ap genome.

PSORTb Version 3.0 has the Ap (strain HZ) genome computed

(http://db.psort.org/browse/genome?id=7470).

All predicted outer membrane proteins

were listed. The confirmed and the well documented outer membrane Msp2(P44) protein
was excluded from all results.

PSORTb comprises six modules to examine protein

sequence. The modules are listed as follows: (1) SCL-BLAST & SCL-BLASTe, searches
proteins against the database of proteins of known subcellular localization. (2) Support
Vector Machines, are machine learning-based classifiers trained to classify a protein as
belonging or not belonging to the set of proteins at a specific localization site. (3) Motif &
Profile Analysis relies on the observation that a proteins function is closely linked to its
localization. (4) Outer Membrane Motif Analysis uses motifs generated from data mining
applied to a set of 425 beta-barrel proteins to classify a query protein as outer membrane or
non-outer membrane. (5) ModHMM identifies transmembrane alpha helices, which in turn
identifies proteins spanning the cytoplasmic membrane.

(6) Signal Peptide directs a

protein for export past the cytoplasmic membrane, and can be used to differentiate
cytoplasmic and non-cytoplasmic proteins. The proteins final location is derived from a
combination of each module.
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CHAPTER 4: Crosslinking and Affinity Purification Approaches to
Capture A. phagocytophilum PSGL-1 Targeting Adhesins

INTRODUCTION
As a more direct means to identify A. phagocytophilum surface proteins as PSGL-1
adhesins, we next chose to test several affinity capture approaches. A. phagocytophilum
recognition of the sLex-modified PSGL-1 N-terminus is a very specific interaction, which
could serve as a means to potentially purify the respective adhesin(s). Affinity purification
allows for the enrichment of a variety of molecules, such as receptor-adhesin, enzymesubstrate and antibody-antigen interactions from complex mixtures (9, 177). Affinity
based approaches using overlays and pull-downs have identified rickettsial adhesins (111,
146) and a heparin binding outer membrane protein of Chlamydia (162).

A

complementary approach that has also been successful in identifying molecular
interactions is chemical crosslinking (120, 172). The advantage of crosslinking is it allows
for noncovalent or transient interactions to be captured, purified and then identified. This
type of approach successfully identified an adhesin of Helicobacter pylori that bound a
fucosylated histo-blood group antigen (8, 86).
To identify adhesins by crosslinking and affinity purification we used
commercially available recombinant human PSGL-1 (rhPSGL-1).
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rhPSGL-1 is a

chimeric protein consisting of the extracellular domain of human PSGL-1 fused to the Fc
region of human IgG1. rhPSGL-1 contains all three receptor determinants essential for A.
phagocytophilum binding as modeled in Figure 3B of Chapter 1. An advantage of using
rhPSGL-1 is the presence of the Fc receptor. The Fc receptor will allow us to purify
rhPSGL-1 with protein A/G beads, as the beads contain high affinity Fc-binding domains.
Using the above approaches and reagents we set out to capture A. phagocytophilum sLexmodified PSGL-1 targeting adhesin(s).

RESULTS
A. phagocytophilum binds immobilized but not soluble rhPSGL-1.
To assess under which conditions A. phagocytophilum binds PSGL-1, we tested
bacterial adherence to rhPSGL-1 in soluble form, as well as to rhPSGL-1 immobilized to
beads. Even though only DC organisms bind PSGL-1 as demonstrated in Chapter 2, at the
onset of this study there were no available techniques to separate RC and DC organisms
from each other. Therefore, we had to isolate and use total bacterial populations consisting
of both RC and DC organisms for experiments.
We first tested the bacterium's ability to bind soluble rhPSGL-1 by mixing the two
together, after which unbound rhPSGL-1 was washed away.

The bacteria were then

solubilized, and the soluble fraction was mixed with Protein A/G beads to recover any
rhPSGL-1 that had bound to the organisms. The initial supernatant, washes and Protein
A/G beads were analyzed by western blot for rhPSGL-1 (Fig. 13). The greatest abundance
of rhPSGL-1 was detected in the initial supernatant. No rhPSGL-1 was detected in the
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Figure 13.

A. phagocytophilum does not bind soluble rhPSGL-1.

Three µg of

rhPSGL-1 was mixed with A. phagocytophilum RC and DC organisms in PBS for 3 h.
Organisms were pelleted and washed to remove unbound rhPSGL-1.

The initial

supernatant removed from the bacterial pellet and the washes were checked for rhPSGL-1.
The bacterial pellet was lysed in RIPA buffer and the soluble fraction was mixed with
Protein A/G beads overnight to bind rhPSGL-1. Protein A/G beads were recovered, boiled
and the eluted sample was resolved by SDS-PAGE and examined by western blot for
recovery of rhPSGL-1. Any recovered rhPSGL-1 would indicate that A. phagocytophilum
adhesin(s) can bind its receptor in soluble form. Representative results of one of two
separate experiments are shown.
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Figure 14. A. phagocytophilum binds to rhPSGL-1 immobilized on beads. Protein
A/G beads were coated with (rhPSGL-1 coated) or without (uncoated) rhPSGL-1 and
blocked with 5% BSA/PBS. A. phagocytophilum RC and DC organisms were mixed in
1% BSA/PBS with rhPSGL-1 coated and uncoated beads for 1 h. Beads were pelleted and
washed to remove unbound organisms, then lysed in RIPA buffer to solubilize any
remaining bound organisms. Samples were resolved by SDS-PAGE and examined by
western blot for Msp2(P44) to determine if organisms bound to the beads. The initial
supernatant, washes and beads were checked for organisms. A. phagocytophilum lysate
served as a positive (Pos.) control for Msp2(P44) detection. Representative results of one
of two separate experiments are shown.
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washes nor was any recovered by the Protein A/G beads, suggesting that A.
phagocytophilum adhesin(s) cannot bind soluble rhPSGL-1. Under reducing conditions
rhPSGL-1 typically migrates around 125 kDa, but occasionally multimers around 250 kDa
can still be detected (Fig 13).
We next tested the organism's ability to bind rhPSGL-1 immobilized on Protein
A/G beads. Protein A/G beads were mixed with rhPSGL-1, resulting in Protein A/G
binding to the IgG1 Fc receptor fused to rhPSGL-1, thus coating the beads with rhPSGL-1.
Beads coated with (rhPSGL-1 coated) and without (uncoated) rhPSGL-1 were blocked in
BSA and then mixed with A. phagocytophilum. After 1 h, the supernatant was removed
and the beads were washed and analyzed by western blot for organisms bound to the beads
(Fig. 14). A. phagocytophilum could be detected specifically binding to the beads coated
with rhPSGL-1, whereas organisms did not bind to beads that lacked rhPSGL-1
(uncoated).

Crosslinking approach to capture A. phagocytophilum PSGL-1 adhesins.
Having determined that

A. phagocytophilum organisms

bind rhPSGL-1

immobilized to Protein A/G beads, we next sought to use this binding event in adjunct with
chemical crosslinking.

The principle of the approach is to allow organisms to bind

rhPSGL-1, at which time a crosslinker is added to form a covalent bond between rhPSGL1 and bacterial adhesin(s). The advantage of this approach is binding occurs in a native
state. Two commercially available crosslinkers, Dithiobis(sulfosuccinimidylpropionate)
(DTSSP) and Sulfo-NHS-SS-Diazirine (Sulfo-SDAD) were used in this study (Fig. 15).
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Figure 15. Crosslinkers utilized during study. Two commercially available crosslinkers
were used in this study. (A) DTSSP is a homobifunctional NHS-ester primary aminereactive crosslinker with a spacer arm length of 12 angstroms (Å). (B) Sulfo-SDAD is a
heterobifunctional crosslinker. The NHS-ester reacts with primary amines, whereas the
diazirine ring when exposed to UV light creates a reactive carbene intermediate to form a
covalent bond with any amino acid side chain or peptide backbone within the spacer arm
distance of 13.6 Å. Both crosslinkers are water soluble and membrane impermeable. Each
crosslinker contains a disulfide bond, allowing for separation of any crosslinked proteins
for downstream analysis.
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Both crosslinkers contain n-hydroxysuccinimide-ester (NHS-ester) that react with amines,
which are typically found in high abundance in proteins due to the amino acid lysine (172).
To identify adhesin(s) by crosslinking, we mixed A. phagocytophilum organisms
with rhPSGL-1 coated or uncoated beads to allow for bacterial binding, followed by the
addition of 5 or 10 mM DTSSP crosslinker to covalently crosslink A. phagocytophilum
adhesin(s) to rhPSGL-1. Bacteria were solubilized, leaving the crosslinkers' covalent bond
between any adhesin(s) and rhPSGL-1 intact. Beads with rhPSGL-1 still bound along with
any crosslinked adhesin(s) were recovered. The recovered beads were analyzed by two
methods to determine if adhesin(s) were captured with crosslinking (Fig. 16).
We first boiled the recovered beads under reducing (with BME) conditions to break
the disulfide bond of the crosslinker to release any adhesin(s) from rhPSGL-1. Samples
were resolved by SDS-PAGE gel and stained with Sypro Ruby protein stain (Fig. 16A)
which has a sensitivity of 1 nanogram (ng), to detect any recovered adhesin(s). All
samples including the negative control of uncoated beads, to which A. phagocytophilum
cannot bind and which no crosslinker was incubated, looked identical. We determined that
the BSA that is required to block the beads and achieve specificity of A. phagocytophilum
binding to rhPSGL-1, is boiled off the beads resulting in very high background staining.
The prominent band of 66 kDa, the known size of BSA, as well as several other BSA
breakdown products are detected. Because of the high background caused by BSA, we
cannot exclude the possibility it could be masking recovered adhesin(s) of low abundance.
As an alternative, we boiled the recovered beads under nonreducing conditions (No BME)
to elute rhPSGL-1 off the beads, keeping the crosslinker intact between rhPSGL-1 and any
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Figure 16. A. phagocytophilum adhesins are not crosslinked to rhPSGL-1 by DTSSP.
Protein A/G beads were coated (rhPSGL-1 coated) with or without (uncoated) rhPSGL-1
and blocked with 5% BSA/PBS. A. phagocytophilum RC and DC organisms were mixed
in 1% BSA/PBS with rhPSGL-1 coated or uncoated beads for 1 h. Beads were washed to
remove unbound organisms followed by the addition of 5 or 10 mM DTSSP crosslinker to
covalently crosslink A. phagocytophilum adhesin(s) bound to or within proximity of
rhPSGL-1. Samples were lysed in RIPA buffer to solubilize the bacteria, which does not
disturb the covalent bonds between any adhesin(s) crosslinked to rhPSGL-1. Beads were
then washed and recovered (rhPSGL-1 remains bound to beads along with any crosslinked
adhesins). Samples were analyzed by Sypro Ruby protein stain (A) and western blot (B).
(A) Recovered beads were boiled under reducing (with BME) conditions to elute any
recovered A. phagocytophilum adhesin(s) crosslinked to rhPSGL-1 and resolved by SDSPAGE gel. Gel was stained with Sypro Ruby protein stain and examined for recovered
proteins. Uncoated beads serve as the negative control. Representative results of one of
two separate experiments are shown.

(B) Recovered beads were boiled under non-

reducing (No BME) conditions to elute rhPSGL-1 from beads along with any attached
adhesin(s). Samples were analyzed by western blot to detect any shifts in rhPSGL-1,
which would indicate crosslinking had occurred. Uncoated beads serve as the negative
control. Representative results of one of two separate experiments are shown.
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adhesin(s). Samples were resolved by SDS-PAGE gel and analyzed by western blot (Fig.
16B) to look for shifts in rhPSGL-1, which would indicate crosslinking of rhPSGL-1 to an
adhesin(s) occurred. No shifts in rhPSGL-1 were detected. We also tested by western blot
and determined that not even the dominant (Msp2[P44]) surface protein of A.
phagocytophilum, was recovered with DTSSP crosslinking (data not shown).
A variety of alternatives conditions were taken to try and troubleshoot these
approaches (data not shown). These included blocking rhPSGL-1 coated beads with dry
milk, and testing bacterial binding in the presence of tween-20, neither of which were
successful. One disadvantage of using the DTSSP crosslinker is its dependence on free
amines for crosslinking.

Because we do not know the surface characteristics of A.

phagocytophilum, we cannot exclude the possibility there are only a few accessible amines.
Therefore we tested the Sulfo-SDAD crosslinker (Fig. 15B) which can react with primary
amines and any amino acid side chain or peptide backbone. We allowed organisms to bind
rhPSGL-1 coated beads, then added Sulfo-SDAD post binding. Alternatively, we labeled
organisms with the amine reactive end of Sulfo-SDAD, allowed the organisms to bind
rhPSGL-1 coated beads, then activated the diazirine ring.

Sulfo-SDAD was also

unsuccessful (data not shown).

Immunoprecipitation approach to capture A. phagocytophilum PSGL-1 adhesins.
Since crosslinking was unsuccessful in capturing adhesin(s), we next tested
immunoprecipitation (IP) as an alternative approach to identify A. phagocytophilum
adhesin(s).

We had found that we can enrich for the adherent DC organisms by
86

Figure 17. Immunoprecipitation was unsuccessful in recovering A. phagocytophilum
adhesins. Protein A/G beads were coated (rhPSGL-1 coated) with or without (uncoated)
rhPSGL-1. A. phagocytophilum DC-enriched organisms or HL-60 controls were lysed in
non-denaturing lysis buffer and incubated with beads overnight. Beads were washed to
remove unbound proteins and then boiled under reducing conditions to elute any
adhesin(s) bound to rhPSGL-1. Samples were resolved by SDS-PAGE gel and stained
with Sypro Ruby to detect recovered proteins. The A. phagocytophilum DC-enriched
lysate mixed with rhPSGL-1 coated beads was resolved in the far right lane.
Representative results of one of five separate experiments are shown.
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sonication of infected cells, which destroy the fragile RC and leave the resistant DC intact
(79). DC-enriched organisms were recovered and lysed in non-denaturing lysis buffer.
The soluble fraction was then mixed overnight with rhPSGL-1 coated beads. Beads were
recovered, washed to remove unbound proteins and boiled to elute any captured adhesin(s).
Samples were resolved by SDS-PAGE gel and stained with Sypro Ruby (Fig. 17).
Because we did not use intact organisms in this experiment it was not necessary to block
the beads with BSA, so we did encounter the high background issues as with the
crosslinking approach. We did not detect any recovered proteins with this approach. A
prominent band of 125 kDa (known size of rhPSGL-1) is detected, as well as several other
rhPSGL-1 breakdown products. The non-denaturing lysis buffer is sufficient in lysing DCenriched organisms as the prominent surface protein Msp2(P44) is detected in the lysate
control. This approach was also tested with A. phagocytophilum DC lysates generated
with denaturing lysis buffer, but was also unsuccessful.

DISCUSSION
Our data was able to demonstrate that A. phagocytophilum organisms only adhere
to PSGL-1 immobilized on a surface. It is not surprising that A. phagocytophilum adhered
to rhPSGL-1 coated beads, as these beads fundamentally mimic HL-60 cells, to which A.
phagocytophilum readily binds (173).

A. phagocytophilum can also bind PSGL-1

glycopeptides immobilized on beads (194), and others in the Carlyon lab determined that
A. phagocytophilum binds rhPSGL-1 coated to the well of an enzyme-linked
immunosorbent assay (ELISA) plate (unpublished data). Although we used both RC and
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DC organisms in many of these binding experiments, we are confident that only DC
organisms bind to rhPSGL-1.
Even though we were unsuccessful in identifying adhesins by crosslinking, it is an
ideal approach as it allows organisms to bind their receptor in a natural state. Other than
the accessibility of binding sites on proteins for the crosslinker, they have no bias or
selective conditions in which to crosslink proteins. As long as two proteins with free
amines are in close enough proximity, they should become crosslinked. Both DTSSP and
Sulfo-SDAD were tested on A. phagocytophilum organisms and shifts in Msp2(P44) were
detectable by western blot (data not shown). This indicates the crosslinkers were properly
functioning and that Msp2(P44) has accessible amines.

The extreme N-termini of

rhPSGL-1 is in close proximity to the region where A. phagocytophilum organisms bind,
which should have been ideal for crosslinking. Crosslinkers should have been sufficient to
recover both soluble and insoluble proteins. The αPSGL-1 Ab (KPL-1) is extremely
sensitive and can detect as little as 0.05 µg of protein (unpublished data).

Even if

adhesin(s) were recovered in low abundance, shifts in rhPSGL-1 should have been
detectable (Fig. 16B).
There are several reasons why crosslinking may have been unsuccessful. First,
when A. phagocytophilum organisms bind PSGL-1, it may do so in a manner where the
whole organism sterically hinders accessibility of the crosslinker from gaining access to
the receptor-adhesin interaction site. Second, free amines have to occur within the distance
of the spacer arm of the crosslinker for crosslinking to occur. If the crosslinker is too
short, and there are not enough accessible amines within proximity of each other,
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crosslinking will not occur. This should have been less of a problem with the crosslinker
Sulfo-SDAD, as it binds amines at one end and any amino acid at the other end.
Nevertheless, use of the crosslinker post binding and labeling organisms pre binding to
rhPSGL-1 was unsuccessful in recovering adhesin(s). Others in the Carlyon lab also tested
labeled rhPSGL-1 with crosslinkers first, allowed organisms to bind, then activated the
crosslinker to capture adhesin(s) (unpublished data). This approach was also unsuccessful.
The use of bacterial lysates has also proven to be equally important in identifying
adhesins (111, 146). The biggest limitation of this approach is the adhesin(s) have to be
soluble, as all insoluble material from lysates is discarded. Given the resistant properties
of the A. phagocytophilum DC, we cannot exclude the possibility some surface proteins are
insoluble and not recovered. However, the facts soluble bacterial lysates did not bind
rhPSGL-1 (Fig. 17) and intact organisms did not bind soluble rhPSGL-1 (Fig. 13) suggest
the affinity of the adhesin or receptor interaction in soluble form is too weak to occur.
When intact organisms bind immobilized PSGL-1 it is a specific and strong interaction.
We believe that multiple adhesins may be involved in binding, but we do not know the
affinity of a given adhesin for its respective receptor determinant. A specific adhesinreceptor interaction could be individually weak, but the synergistic effect of all the
adhesins working together may support strong binding of intact organisms. If this were
true, once the adhesins are isolated from the membrane they may not have a strong enough
affinity for their individual receptor determinants to be isolated and identified.
The structural requirements required for binding at this time are also unknown. We
cannot exclude the possibility that an adhesin could be a complex of proteins. Surface
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proteins within a heterodimer complex of the veterinary pathogen A. marginale were found
to be an adhesin for erythrocytes (21, 38, 91). If a complex of proteins is required for A.
phagocytophilum binding, this will be disrupted when generating lysates. We also cannot
exclude the importance of protein conformation during binding. When P-selectin binds
sialic acid on PSGL-1, a conformational epitope is required (161). It is possible that the
structural requirements of the adhesin required for binding sLex-modified PSGL-1 is only
found on intact organisms and when denatured may result in the loss of adhesin activity.
Non-denaturing lysis buffers should increase the chance of recovering proteins in a native
state with IPs (22), but did not appear successful when tested with A. phagocytophilum
(Fig. 17).
In conclusion, we determined adherence of A. phagocytophilum to sLex-modified
PSGL-1 must occur on a fixed surface, whether it is HL-60 cells, beads or ELISA plates.
The data presented here as well as other unpublished data from the Carlyon lab,
demonstrates known methods used in the recovery of other bacterial adhesins were
unsuccessful in recovering A. phagocytophilum adhesins. A. phagocytophilum adhesion to
PSGL-1 appears to be a very complex scenario, one that we are determined to solve.

METHODS
Mixing soluble rhPSGL-1 with A. phagocytophilum. Ap RC and DC organisms (strain
NCH-1) were recovered by syringe lysis as described (27) from 200 ml of culture and
mixed in a total of 100 microliters (µl) PBS containing 3 micrograms (µg) rhPSGL-1
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(R&D Systems; Minneapolis, MN, Cat. No. 3345-PS) with protease inhibitors (Roche;
Indianapolis, IN, Cat. No. 118361153001) for 3 h at 4°C with rotation. Bacteria were
pelleted at 10,000 x g for 6 min at 4°C and were washed 2 times with 1 ml cold PBS
(supernatant from initial spin and washes were saved for western blot analysis). Bacteria
were lysed in 1 ml of radioimmunoprecipitation assay (RIPA) buffer (50 mM Tris pH 7.4,
1% Nonidet P-40, 0.25% sodium deoxycholate, 150 mM sodium chloride [NaCl], 1 mM
EDTA, 1 mM sodium orthovanadate [Na3VO4] and 1mM sodium fluoride[NaF]) with
protease inhibitors for 45 min on ice. Insoluble material was removed at 10,000 x g for 10
min after which the soluble fraction was mixed with 25 µl of Protein A/G beads (Pierce;
Waltham, MA, Cat. No. 20421) overnight (O/N) at 4°C with rotation. Beads were pelleted
at 3,000 x g at 4°C for 1 min and washed with 1 ml cold PBS 3 times. Forty µl of
Laemmli 2X sample buffer (Bio-Rad; Hercules, CA, Cat. No. 161-0737) with 5% BME
(Fisher Scientific; Pittsburgh PA, Cat. No. BP176-100) was added to beads and boiled for
5 min at 100°C. Beads were pelleted at 3,000 x g for 1 min, supernatant was saved and
analyzed for rhPSGL-1. 25 µl of supernatant (wash steps) was mixed with equal volumes
of 2X sample buffer with 5% BME and boiled for 5 min at 100°C.
Samples were resolved on 4-15% Tris-HCl gel (Bio-Rad Cat. No. 161-1158) at
115v for 15 min and 130v for 45 min and then transferred to nitrocellulose at 100v for 1 h.
The blot was blocked in 5% milk in tris-buffered saline with 5% tween-20 (TBS-t[0.5%])
O/N at 4°C. Primary antibody (Ab) mouse anti-PSGL-1 (KPL-1) (BD Pharmingen; San
Diego, CA, Cat. No. 556053) was added at room temperature (RT) for 1 h at 1:2,000
dilution in 1% milk-TBS-t(0.5%). The blot was washed for 5, 5, 15, 5, and 5 min in TBS93

t(0.5%). Secondary Ab anti-mouse IgG horseradish peroxidase (HRP)-conjugated (Cell
Signaling; Danvers, MA, Cat. No. 7076) was added at RT for 1 h at 1:30,000 dilution in
1% milk-TBS-t(0.5%). The blot was washed for 5, 5, 15, 5, and 5 min in TBS-t(0.5%).
The blot was incubated with SuperSignal West Pico chemiluminescent substrate (Pierce,
Cat. No. 34080) for 5 min and exposed to film (Pierce, Cat. No. 34091).

A. phagocytophilum binding to Protein A/G beads coated with rhPSGL-1. 10 µg of
rhPSGL-1 was mixed with 25 µl of Protein A/G beads in 1 ml PBS with protease inhibitors
O/N. The next day, beads were pelleted at 3,000 x g for 30 seconds (sec) and supernatant
discarded. 1 ml of 5% bovine serum albumin (BSA)/PBS was added for 1 h at RT with
rotation to block beads. Uncoated beads were prepared in same manner without the
addition of rhPSGL-1. Ap RC and DC organisms (strain NCH-1) were recovered by
syringe lysis as described (27) from 120 ml of culture and split equally with rhPSGL-1
coated and uncoated beads in 1 ml of 1% BSA/PBS for 1 h at RT with rotation. Beads
were pelleted at 1,000 x g for 1 min at RT and washed 3 times with 1 ml PBS. Supernatant
from initial spin and washes were saved and centrifuged at 10,000 x g for 6 min to test for
Ap. rhPSGL-1 coated, uncoated beads and Ap recovered from supernatant and washes
were lysed in 250 µl of RIPA buffer with protease inhibitors for 45 min on ice. Insoluble
material and beads were removed by spinning at 10,000 x g for 10 min. Twenty-five µl of
supernatants were mixed with 25 µl of Laemmli 2X sample buffer with 5% BME and
boiled for 5 min at 100°C.
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Samples were resolved on 4-15% Tris-HCl gel at 115v for 15 min and 130v for 45
min and transferred to nitrocellulose at 100v for 1 h. Blot was blocked in 5% milk-TBSt(0.5%) O/N at 4°C. Primary Ab rabbit anti-Ap was added at RT for 1 h at 1:10,000
dilution in 1 % milk-TBS-t(0.5%). The blot was washed for 5, 5, 15, 5, and 5 min in TBSt(0.5%). Secondary Ab anti-rabbit IgG HRP-conjugated (Cell Signaling, Cat. No. 7074)
was added at RT for 1 h at 1:20,000 dilution in 1 % milk-TBS-t(0.5%). The blot was
washed for 5, 5, 15, 5, and 5 min in TBS-t(0.5%).

The blot was incubated with

SuperSignal West Pico chemiluminescent substrate for 5 min and exposed to film.

Crosslinking A. phagocytophilum adhesins to rhPSGL-1 with DTSSP.

Ap (strain

NCH-1) was mixed with rhPSGL-1 coated and uncoated beads as described above.
Unbound organisms were washed off and beads were split equally into two samples and
resuspended in 1 ml of 5 or 10 mM DTSSP (Pierce, Cat. No. 21578) for rhPSGL-1 coated
beads or PBS and 5 mM DTSSP for uncoated beads and incubated for 30 min at RT with
rotation.

Tris was added to a final concentration of 20 mM for 15 min to quench

crosslinker. Beads were pelleted at 1,000 x g for 1 min at RT, and washed with 1 ml cold
PBS. Beads were lysed in 250 µl RIPA buffer with protease inhibitors for 45 min on ice.
Beads (with rhPSGL-1 still bound) were pelleted at 1,000 x g for 1 min and washed 4
times in 1 m of cold PBS. 40 µl of Laemmli 2X sample buffer with 10% BME was added
and boiled for 5 min at 100°C.
Beads were pelleted at 3,000 x g for 1 min, supernatant was saved and analyzed for
recovery of Ap adhesin(s). Samples were resolved on 4-15% Tris-HCl gels at 115v for 15
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min and 130v for 45 min. Gels were stained with Sypro Ruby (Invitrogen; Carlsbad, CA,
Cat. No. S-12000) according to manufactures instructions and imaged with trans UV on
ChemiDoc XRS imager (Bio-Rad). In some experiments, samples were eluted from beads
under non-reducing conditions (No BME), resolved by SDS-PAGE and transferred to
nitrocellulose at 100v for 1 h.

Blots were screened with α PSGL-1 (KPL-1 Ab) as

described above.

Immunoprecipitation with rhPSGL-1 coated beads using non-denatured A.
phagocytophilum lysate.

rhPSGL-1 coated and uncoated beads were prepared as

described above. Ap DC-enriched organisms (strain NCH-1) were recovered from 400 ml
of culture by sonication as described (79). Ap was lysed in 1 ml of non-denaturing lysis
buffer (1% w/v Triton-X-100, 0.02% w/v sodium azide, 50 mM Tris-HCl pH 7.4, 300 mM
NaCl, 5 mM EDTA, 10 mM iodoacetamide, 2 µg/ml leupeptin and 1 mM
phenylmethylsulfonyl fluoride [PMSF]) at 4°C for 45 min with rotation.

Insoluble

material was removed by spinning at 10,000 x g for 10 min. Supernatants were split
equally among samples. Equal numbers of uninfected HL-60 cells were prepared in the
same manner as infected cells to serve as negative controls. All samples were mixed with
rhPSGL-1 coated or uncoated beads in a total of 1 ml non-denaturing lysis buffer O/N at
4°C with rotation. The next day, beads were pelleted at 1,000 x g for 1 min and washed 3
times with 1 ml cold PBS. 40 µl of Laemmli 2X sample buffer with 5% BME was added
to the washed beads and boiled for 5 min at 100°C. Beads were pelleted at 3,000 x g for 1
min, supernatant was saved and analyzed for recovery of Ap adhesin(s). Samples were
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resolved on 4-15% Tris-HCl gels at 115v for 15 min and 130v for 45 min. Gels were
stained with Sypro Ruby according to manufactures instructions and imaged with trans UV
on ChemiDoc XRS imager (Bio-Rad).

97

CHAPTER 5: Identification of Putative A. phagocytophilum DenseCored Cell Outer Membrane Proteins by Density-gradient
Centrifugation, Biotinylation and Mass Spectrometry

INTRODUCTION
In view of the fact that we were unable to capture or purify A. phagocytophilum
adhesins by receptor crosslinking and affinity purification, we next chose to take a broader
approach to identify OMPs of the adherent DC. The biphasic development cycle exhibited
by A. phagocytophilum was first documented to occur and is most well studied in
Chlamydia species. For some research purposes, it is essential to purify these intracellular
bacteria away from their host cell components. Separation of the noninfectious RB and
infectious EB developmental forms of Chlamydia from each other and removal of host cell
debris has been accomplished by the use of Renografin density-gradient centrifugation (99,
156). Separation of different developmental forms and removal of host cell debris with
density-gradient centrifugation has also been accomplished for intracellular pathogens
within the order Rickettsiales as well as for Coxiella burnetii (65, 187-190, 198).
Due to the relatively recent discovery of human infections in 1994 (34),
standardized techniques in use for other organisms have not yet been fully developed for
the study of A. phagocytophilum. An example is the inability thus far to separate the A.
phagocytophilum replicative RC and the adherent DC forms from each other. To date,
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Renografin density-gradient centrifugation has only been able to separate both RC and DC
organisms mixed together from host cell debris (27). To identify OMPs of the adherent
DC form we chose to use the sonication resistant properties of the DC for their selection,
followed by Renografin discontinuous density-gradient centrifugation to remove host cell
debris. We then used biotinylation to label surface proteins, a proven method previously
validated to work with A. phagocytophilum and other organisms (25, 55, 88, 138, 141,
153). Biotinylated OMPs were purified and then identified by mass spectrometry (MS).

RESULTS
The A. phagocytophilum dense-cored cell is resistant to sonication.
The infectious EB of Chlamydia is very environmentally resistant and stable due to
extensive crosslinking of disulfide bonds within its membrane (67). The EB's stability
allows it to survive treatments with both detergents and sonication that destroy the fragile
replicative RB (68, 156, 167).

To determine if the A. phagocytophilum DC is

environmentally resistant, we compared the conventional isolation method of syringe lysis
to sonication.

Samples were monitored for RC and DC organisms by TEM before

isolation, after syringe lysis and after sonication.
Organisms for experiments are isolated from cultures of asynchronously infected
cells (Fig. 18A) containing both RC and DC organisms. The abundance of RC and DC
organisms in a given culture before use in experiments cannot be determined at this time,
as there are no antibodies or differently expressed markers to distinguish between the two
developmental forms. Data from Chapter 2 demonstrates that even from a synchronous
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Figure 18. A. phagocytophilum organisms at various stages of isolation examined by
transmission electron microscopy. (A) Infected HL-60 cells. Infected cells containing
both RC and DC organisms are the starting material for all experiments. (B) Syringe lysis.
Both RC and DC organisms mixed with some host cell debris were recovered by syringe
lysis.

(C) Sonication. Infected cells were sonicated to destroy the host cell and fragile

RC organisms, leaving the environmentally resistant DC intact. White arrowheads denote
RC and grey arrows denote DC organisms. All scale bars 1 µm.
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infection, the best time to recover the greatest abundance of organisms is late in infection
after the culture has become asynchronous and the cells are heavily infected (Fig. 8B).
The population of the DC in these asynchronous cultures is approximately 30-55% (Table
1). The standard method of isolating A. phagocytophilum for experiments is syringe lysis.
We observed that this method is best suited for recovery of a mixture of both RC and DC
organisms, which is also mixed with host cell debris (Fig. 18B). To test whether or not the
A. phagocytophilum DC is environmentally resistant, former Carlyon lab member Nathan
Galloway sonicated infected cells from 32 up to160 sec. The DC was able to remain
visually intact even after 160 sec of sonication as observed by TEM (data not shown). We
chose to use 64 sec of sonication for experiments as this was the minimum time required
for destruction of the host cells and RC organisms (Fig. 18C).

Renografin purification and biotinylation of A. phagocytophilum DC OMPs.
Establishing that sonication was an efficient means to destroy RC organisms while
leaving the DC form intact, we next used this technique in combination with the published
protocol of Renografin discontinuous density-gradient centrifugation (27) to purify the DC
organisms and reduce the amount of cellular debris. Figure 19A is a representative TEM
image of sonicated DC organisms recovered after Renografin purification.
The purified DC organisms were then mixed with an excess of the water soluble,
non-membrane permeable Sulfo-NHS-SS-Biotin to label OMPs. Bacteria were solubilized
in RIPA buffer, and the soluble fraction was mixed with NeutrAvidin beads to recover
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Figure 19.

Density-gradient purified DC organisms and recovered biotinylated

putative surface proteins. Infected cells were sonicated to enrich for DC organisms, and
then purified by Renografin discontinuous density-gradient centrifugation.

(A) TEM

image of DC organisms recovered between the 30% - 42% Renografin interface. Grey
arrows denote DC organisms. Scale bar 1 µm. (B) Renografin density-gradient purified
DC OMPs were labeled with the non-membrane permeable Sulfo-NHS-SS-Biotin.
Bacteria were lysed in RIPA buffer and soluble biotinylated proteins were purified with
NeutrAvidin Beads. Recovered biotinylated proteins were resolved by SDS-PAGE and
examined by silver stain (lane 1). A whole cell lysate control was resolved in lane 2. The
dominant Ap surface protein Msp2(P44) is indicated.
experiment are shown.
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Representative results of one
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biotinylated proteins. Recovered proteins were resolved by SDS-PAGE and examined by
silver stain. Selective enrichment of specific proteins can be observed in lane 1 when
compared to the whole cell lysate control of lane 2 (Fig. 19B).

The dominant A.

phagocytophilum surface protein Msp2(P44) is clearly enriched with biotinylation, as
would be expected due to its known surface localization.

Identification of recovered proteins by mass spectrometry.
To identify recovered A. phagocytophilum proteins, we chose to use a type of MS
referred to as multi-dimensional protein identification technology (MudPIT). MudPIT is
suited to identify hundreds of proteins from complex mixtures (108). It allows peptides to
be separated by 2D liquid chromatography, thus eliminating the need to resolve samples by
From our biotinylation approach, MudPIT identified a total of 55 A.

gels.

phagocytophilum proteins (Table 5).

However, only 16 of these proteins can be

confidently accepted as an authentic result with a 1% chance of error. For proteins to be
considered authentic they should have a confidence score of above 300 with several
recovered peptides. Proteins below this threshold have a higher probability of being a false
positive.

MudPIT also confidently identified 153 human proteins (data not shown),

indicating that the sample still had considerable host cell debris contamination.

DISCUSSION
Our data demonstrates that the A. phagocytophilum DC is environmentally resistant
and is capable of surviving mechanical means of disruption, a property that we were able
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Table 5. Putative Ap biotinylated OMPs identified by MudPIT
Ap gene

kDaa

Protein description

Score

Peptides

Coverageb

1

APH_1221

45.8

P44 18ES OMP

20,608

131

78

2

APH_1235

14.7

hypothetical protein

4,191

33

92

3

APH_0240

58.2

chaperonin GroEL

1,437

69

69

4

APH_0494

51.5

ATP synthase subunit

641

32

59

5

APH_0405

57.5

hypothetical protein (Asp55)

490

27

46

6

APH_1087

26.1

putative lipoprotein

458

10

37

7

APH_1032

42.8

elongation factor Tu

415

19

45

8

APH_1190

18.8

ATP synthase subunit

415

2

14

9

APH_0404

63.6

hypothetical protein (Asp62)

413

21

27

10

APH_0397

32.1

30S ribosomal protein S2

406

12

33

11

APH_0036

22.6

co chaperone GrpE

395

4

33

12

APH_1404

46.9

T4SS protein VirB10

389

8

23

13

APH_0346

69.7

chaperone protein DnaK

381

25

34

14

APH_0248

13.8

hypothetical protein

359

10

58

15

APH_1049

23.3

major surface protein 5

354

4

22

16

APH_1334

54.1

ATP synthase subunit alpha

312

30

35

17

APH_0051

37.3

iron binding protein

253

4

15

18

APH_0853

10.8

hypothetical protein

250

4

63

19

APH_0625

34.7

immunogenic protein

229

6

29

20

APH_1050

37.6

putative ABC transporter

221

3

17

21

APH_1246

52.4

glutamine synthetase type I

216

9

10

22

APH_1232

45.6

citrate synthase I

214

5

20

23

APH_0600

61.5

thiamine biosynthesis - ThiC

203

4

11

24

APH_0059

39.2

phenylalanyl tRNA synthetase

197

7

14

25

APH_0555

51.8

cysteinyl tRNA synthetase

193

5

19

26

APH_0985

19.8

putative lipoprotein

185

1

14

27

APH_0794

27.1

hypothetical protein

184

2

8

28

APH_0740

131.1

ankyrin

183

11

7

29

APH_1258

32.7

fructose bisphosphate aldolase

182

5

9

30

APH_0723

27.2

hypothetical protein

182

1

3

31

APH_1025

14.1

50S ribosomal protein L7 L12

181

2

24

32

APH_1292

42.0

cell division protein FtsZ

181

3

13

33

APH_1210

85.7

OMP85 family OMP

174

7

8

34

APH_0130

20.6

triphosphate deaminase

172

1

5

35

APH_0283

29.8

50S ribosomal protein L2

170

3

8

106

36

APH_0893

71.1

heat shock protein 90

168

6

13

37

APH_1412

16.0

hypothetical protein

168

1

7

38

APH_1217

15.6

nucleoside diphosphate kinase

167

1

10

39

APH_0111

26.3

uridylate kinase

164

2

13

40

APH_1151

21.4

hypothetical protein

162

1

5

41

APH_0608

67.4

ppiC parvulin rotamase protein

161

10

13

42

APH_1359

31.6

major OMP 1A

158

2

6

43

APH_1084

29.8

cytochrome c oxidase subunit II

155

3

13

44

APH_0422

35.7

acetylglutamate kinase

152

2

7

45

APH_0792

37.6

hypothetical protein

149

1

3

46

APH_1219

33.4

Omp 1X

145

1

5

47

APH_0971

49.4

putative trigger factor

141

3

13

48

APH_0038

59.4

CTP synthetase

140

2

6

49

APH_0669

114.5

proline dehydrogenase

139

4

7

50

APH_0450

86.7

ATP dependent Clp protease

138

2

2

51

APH_0386

58.6

HGE 14 protein

135

1

2

52

APH_0231

54.6

leucyl aminopeptidase

129

3

11

53

APH_0678

63.4

chaperone protein HscA

127

1

5

54

APH_0393

49.0

dihydrolipoamide dehydrogenase

127

1

2

55

APH_0874

115.4

hypothetical protein

123

5

3

Proteins above the dashed line are 99% authentic with only a 1% false-discovery rate
a
Size of identified protein
b
Percentage of protein coverage
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to use in its isolation. The focus of this study was to identify surface proteins of the A.
phagocytophilum DC, using improved purification approaches.

We observed several

limitations when surface proteins of A. phagocytophilum were previously identified (55).
First, both RC and DC organisms were used for OMP identification. For our purposes, we
only used the adherent DC organism in this study, as our goal is to identify OMPs as
putative adhesins. Second, some of previously identified proteins may not have been
surface exposed if the biotin reagent gained access through functional porins (25) to label
inner membrane proteins. Although we did not control for this issue, it is unlikely to be a
problem with DC organisms.

Porins function as a transport conduits through which

various molecules such as nutrients can pass (130). A. phagocytophilum has porins (80),
but they are most likely only active on the RC during intracellular growth and replication.
The sonication-resistant feature of the DC further demonstrates that its function is to
survive harsh extracellular environments during dissemination.

It would be

disadvantageous for the organisms to have functional porins outside the cell in a
potentially hostile environment.

Indeed, the Coxiella small cell-variant (SCV) and

Chlamydia EBs either down regulate proteins that function as porins or heavily crosslink
the surface, thereby ceasing porin function on their respective infectious forms (17, 180).
A third limitation of the previous study was that only a select few bands from a 1D SDSPAGE gel were chosen for analysis. Our use of MudPIT, which does not require proteins
to be resolved on a gel, eliminates any bias by detecting all recovered biotinylated proteins.
Previously, only 14 putative A. phagocytophilum surface proteins were identified
with biotinylation (55), of which only 3 have been confirmed as surface localized. Our
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biotinylation approach of the DC recovered 55 proteins. However, only 16 proteins could
be confidently identified as an authentic result.

Of the proteins that we confidently

identified, 3 were known surface proteins (Msp2[P44], Asp55 [APH_0405] and Asp62
[APH_0404]). Of all 55 proteins we potentially identified, 9 of these were identified in the
previous study. They were Msp2(p44), APH_0036, 0240, 0346, 0404, 0405, 0608, 1210
and 1359. All but 3 of these proteins (APH_0608, 1210 and 1359) were confidently
identified in our analysis.

We also confidently identified Msp5 (APH_1049), a well

conserved protein amongst Anaplasma species (163).
Even though our study corroborates the previous biotinylation study, some of the
recovered proteins are not ones that would be expected to be surface exposed, while others
appear to be missing. A total of 3 chaperones GroEL (APH_0240), GrpE (APH_0036) and
DnaK (APH_0346) were confidently identified. Chaperones assist in protein folding in the
cytoplasm (77), and would not be expected as surface exposed proteins. The same is true
of elongation factor Tu (APH_1032), which is associated with the ribosome (131). As odd
as it may be for these proteins to be surface exposed, some evidence not only suggests they
are on the surface in some instances, but also act as adhesins. Elongation factor Tu of
Lactobacillus johnsonii has been demonstrated to mediate attachment to human intestinal
cells and mucins (63). Whereas GroEL of both Lactobacillus johnsonii and Plesiomonas
shigelloides has also demonstrated adhesin function (19, 175). It may be predicted that
because the DCs chromatin is compacted, the organism is likely to be metabolically
inactive and thus would not require chaperones. Nonetheless, characterization of the
proteome of the infectious Chlamydial EB has found many proteins associated with
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metabolism, replication, and protein folding (159, 179).

These proteins are likely

prepackaged in the infectious form so the organisms can quickly use them upon entry into
a host cell for replication and intracellular survival. Two other confidently identified
proteins, APH_1235 and APH_0248 were of interest due to their small sizes of 14.7 and
13.8 kDa, respectively. It is interesting to speculate how such small proteins are integrated
into the membrane. Proteins such as these would not be predicted as OMPs, as their small
size would prevent them from containing enough structural features to allow them to be
classified as traditional membrane proteins. One group of proteins that would have been
expected to be recovered are the A. phagocytophilum T4SS components (133). DCs
should express the T4SS, as AnkA is delivered into host cells upon bacterial binding. Of
all the T4SS components, only VirB10 was detected. VirB10 is predicted to localize
within the inner membrane, yet all the outer membrane protein components of the T4SS
(32), VirB2, VirB3, VirB5, VirB7 and VirB9 were not detected.
The unusual ability of A. phagocytophilum to bind human PSGL-1 suggest that the
adhesin(s) are unusual as well. Even though chaperones GroEL, GrpE , DnaK as well as
elongation factor Tu may be unusual if they localize to the surface of A. phagocytophilum,
it does not yet directly implicate them as adhesin(s). Some of these proteins as well as
predicted OMPs APH_1210 (OMP85 family) and APH_1359 (OMP 1A) have very high
protein sequence homologies to other bacterial species (data not shown). This raises the
question of how could these proteins. if adhesin(s), achieve specificity of binding to
PSGL-1 for A. phagocytophilum if also expressed on the outer membrane of other
pathogens. We presume that we are looking for unique proteins. This would include
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hypothetical proteins, as these proteins are predicted to existence, but for which there is no
experimental evidence that they are expressed in vivo. They can also have little homology
to other proteins of known function.

The A. phagocytophilum genome contains 540

hypothetical proteins, comprising 38.3% of the genome.
Overall, our approach of purification and biotinylation of the DC was successful in
recovering known and potentially new OMPs. However, there are several limitations of
this experimental approach that will need to be addressed further for us to be confident that
we are truly identifying DC specific OMPs. One concern is the volume of contaminating
cellular debris. We confidently identified 153 human proteins (derived from HL-60 cells),
but only 16 A. phagocytophilum proteins. Debris contamination was visually observed by
TEM as well (Fig. 19A). An excess of debris could interfere with efficient labeling of
OMPs on the DC, preventing recovery of low abundant proteins.

The published

Renografin density-gradient centrifugation protocol has only been tested on recovering
organisms from syringe lysis (27) and the purity of the organisms was never confirmed by
TEM.

We did not take into consideration that sonication generates very fine debris

particles that could not be readily removed. We have since tried different sonication times
and added more gradient layers, but were unsuccessful in eliminating debris from
comigrating with A. phagocytophilum DC organisms. A greater concern is whether or not
this debris could contain destroyed RC organisms.

If debris from RC organisms

comigrates with the DC, then we cannot be confident that the proteins we identified are
truly DC-specific or even surface proteins. It is possible that some identified proteins
could be derived from the RC cytoplasm.
111

Indeed, one of the confidently identified

proteins was 30S ribosomal protein S2 (APH_0397). Also, many of the proteins we
identified, albeit of low confidence, are associated with metabolism. Generally, these
proteins would not be predicted to be surface exposed. Another concern is we also have to
question how efficient RIPA buffer extracts surface proteins from the membrane given the
resistant nature of the A. phagocytophilum DC. Although RIPA buffer is commonly used
for lysing A. phagocytophilum and most certainly can solubilize surface proteins, the
efficiency of extraction is unknown. Msp2(P44) was easily recovered and confidently
detected, yet predicted OMPs APH_1210 (OMP85) and APH_1359 (OMP1A) were also
identified, but below a confident level. The low level of OMP85 and OMP1A may simply
be due to low levels of expression on the DC or due to inefficient extraction from the outer
membrane.
Many of the proteins identified in this study are likely surface proteins as the
results corroborate well with a previous biotinylation study of A. phagocytophilum (55).
Although the above concerns will have to be addressed in future experiments, proteins
identified from this study are currently being investigated by other members of the Carlyon
lab. The remainder of my dissertation was to focus on improving gradient purification as a
means to isolate pure DC organisms.

METHODS
A. phagocytophilum organisms at various stages of isolation examined by transmission
electron microscopy. Infected HL-60 cells were pelleted at 300 x g for 5 min, supernatant
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was discarded and cell pellet was processed for TEM. All samples were processed for
TEM as previously described (173).

Ap RC and DC organisms (strain NCH-1) were

recovered by syringe lysis as follows. Heavily infected HL-60 cells with high bacterial
loads were pelleted at 5,000 x g for 15 min at 4°C. Cells were resuspended in a total of 9
ml cold PBS with protease inhibitors (Roche; Indianapolis, IN, Cat. No. 11836153001) for
every 250 x 106 cells. Cells were lysed by 5 passages through a 27½ gauge needle (BD;
Franklin Lakes, NJ, Cat. Nos. 305196, 305109) in a 50 ml tube.

The sample was

distributed at a ratio of 100 x 106 cells in 45 ml PBS and centrifuged at 1,200 x g for 10
minutes at 4°C to pellet large debris. The supernatant was transferred to new tube and
centrifuged at 4,500 x g for 15 minutes at 4°C to pellet Ap. The bacterial pellet was
processed for TEM. DC organisms were recovered by sonication as follows. Heavily
infected HL-60 cells with high bacterial loads were pelleted at 5,000 x g for 15 min at 4°C.
Cells were resuspended in 6 ml cold PBS with protease inhibitors for every 250 x 106 cells,
and subjected to eight 8-sec bursts on ice interspersed with 8-sec rest periods using a
Misonix S4000 ultrasonic processor (Farmingdale, NY) on an amplitude setting of 30. The
6 ml sample was brought up to 50 ml with PBS and centrifuged at 750 x g for 5 minutes at
4°C to pellet large debris. Supernatant was transferred to a new tube and centrifuged at
1,000 x g for 10 minutes at 4°C to remove more debris. Supernatant was transferred to a
new tube and centrifuged at 4,500 x g for 10 minutes at 4°C to pellet Ap. The bacterial
pellet was processed for TEM.
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Renografin purification of A. phagocytophilum DC organisms. DC organisms were
recovered by sonication and differential centrifugation as described above. Ap pellet from
500 x 106 cells was resuspended in 10 ml PBS with 0.2% glucose and treated with 50
µg/ml of DNAse I (Roche, Cat. No. 10104159001) for 45 min at 37°C. The sample was
then layered on top of 30% - 42% discontinuous Renografin gradient, centrifuged, and
organisms were recovered from 30% - 42 % interface as previously described (27).

Biotinylation and purification of A. phagocytophilum DC surface proteins.

DC

organisms recovered from the Renografin gradient were washed 2 times in 1 ml cold PBS
at 5,000 x g for 5 minutes. For biotinylation, Ap recovered from up to 1 x 109 cells was
mixed in 1 ml PBS with 10 mM water soluble non-membrane permeable Sulfo-NHS-SSBiotin (Pierce; Waltham, MA, Cat. No. 21331) for 30 min at RT with rotation. Organisms
were pelleted at 5,000 x g for 5 min and the supernatant was discarded. The Ap pellet was
thoroughly resuspended in 1 ml of 50 mM Tris (pH 8.0) to quench the biotinylation
reagent. Ap pellet was washed two more times with 500 µl cold PBS. The Ap pellet was
lysed in 1 ml RIPA solution with protease inhibitors for 1 h on ice. Every 20 min, the
sample was subjected to sonication on an amplitude setting of 30 for four 8-sec bursts on
ice interspersed with 8-sec rest periods. Insoluble material was removed by centrifugation
for 10 min at 10,000 x g at 4°C. The supernatant was saved and transferred to ice.
The soluble fraction of the biotinylated sample was mixed with High Capacity
NeutrAvidin Agarose Beads (Pierce, Cat. No. 29202) in 10 ml RIPA buffer with protease
inhibitors O/N at 4°C with rotation. The sample was centrifuged at 1,000 x g for 1 min,
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supernatant was removed (saved to verify purification of biotinylated proteins) and beads
were resuspended in 10 ml cold PBS. The sample was centrifuged again at 1,000 x g for 1
min and the supernatant was discarded. The beads were resuspended in 8 ml cold PBS.
The sample was thoroughly mixed and 800 µl aliquots of slurry were removed from the
tube and placed in one spin column (Pierce, Cat. No. 69725) a total of 10 times. Columns
were centrifuged at 1,000 x g for 1 min at 4°C. The flow through was discarded. Five
hundred µl of cold PBS was added to the column, mixed and centrifuged again for a total
of 3 washes. A cap was placed on the bottom of spin column tube. Five hundred µl of
0.25% Na deoxycholate solution with 150 mM dithiothreitol (DTT) was added to the
column. The tube lid was closed and the sample was mixed for 2 h at RT with rotation.
The cap from the bottom of the tube was removed and proteins were eluted into a new
clean tube by spinning at 1,000 x g for 2 minutes. All recovered/eluted samples were
pooled into one tube and placed on ice.

The sample concentration was determined.

Sample was stored at 4°C to prevent proteins from falling out of solution.

MS identification of A. phagocytophilum DC surface proteins.

Two hundred µg

purified biotinylated sample was concentrated with ultra-0.5ml centrifugal filter units
(Fisher Scientific; Pittsburgh, PA, Cat. No. UFC501024). Four hundred µl of sample was
added as many times as needed to the centrifugal filter and centrifuged at 10,000 x g at RT
to reduce the retentate to <50 µl.

Upon reduction, 400 µl of 50 mM ammonium

bicarbonate (ABC) buffer with 0.05% Na deoxycholate was added and the sample was
centrifuged at 10,000 x g at RT to reduce the retentate. The wash was repeated a second
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time and centrifuged to near dryness. Filters were inverted and placed into new microfuge
tubes, which were centrifuged at 3,000 x g at RT for 10 min to collect retentate. The
eluted volume was measured. The eluted volume was subtracted from 25 µl. A 90:10 (50
mM ABC / Acetonitrile [ACN]) buffer of the subtracted volume was added to the top of
the filter and incubated for 15 min. The sample was eluted into the previously collected
sample to yield a total volume of 25 µl. One µl of fresh 500 mM DTT made in 50 mM
ABC was added to sample and incubated for 30 min at 90°C. The sample was then cooled
to room temperature. Trypsin (Promega; Madison, WI, Cat. No. V5280) (100 ng/µl) was
added to a final 1:100 enzyme:protein ratio (20 µl trypsin for 200 µg of protein). If a
precipitate formed, then 0.5 µl ammonium hydroxide was added to the sample. The
sample was vortexed briefly and placed at 37°C O/N. Samples were analyzed by MudPIT.
Recovered peptide spectra data was search against the A. phagocytophilum (strain HZ) and
human genome. All identified A. phagocytophilum proteins were reported.
For protein identification to be considered an authentic result, we determined that
the protein needed to have a minimal score of 300 with multiple recovered peptides. This
would allow for identified proteins to be considered as 99% authentic with only a 1%
chance of error. The score of the identified protein is the sum of several values, which
includes the number of peptides recovered and percent coverage of proteins. The number
of peptides identified is derived from the total number of different ion measurements.
These ion measurements depend on how a protein is digested and will include peptides that
can contain multiple overlapping sequences from the same region of a protein.

The

proteins in Table 5 are ranked by score, which is generally related to the abundance of a
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given protein.

The more protein present in a sample, the more peptides should be

recovered and the better score the protein will receive.
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CHAPTER 6: Density-gradient Purification of the A. phagocytophilum
Reticulate Cell and Dense-Cored Cell Forms

INTRODUCTION
Our ability to confidently identify OMPs as adhesin(s) is dependent on isolation of
the adherent A. phagocytophilum DC.

In the previous chapter, we were able to

demonstrate that sonication combined with discontinuous density-gradient centrifugation
was successful in recovering DC organisms, but we could not be confident that
contamination from destroyed RC organisms did not occur. The large abundance of host
cell debris contamination generated from sonication was also an issue, as it could interfere
with biotinylation and MS identification of A. phagocytophilum proteins.

Therefore,

individual separation of undamaged RC and DC organisms will be required to ensure we
identify and pursue only DC specific surface proteins.
Separation of the different biphasic developmental forms has been achieved with
gradient-centrifugation for Chlamydia species and Coxiella burnetii (36, 156). Isolation
and characterization of pure developmental forms has allowed great insight into their
structures and functions. Because separation of RC and DC organisms has not been
established for A. phagocytophilum, we set out to devise new methods to individually
separate the two forms by means of discontinuous density-gradient centrifugation.
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RESULTS
Isolation and purification of A. phagocytophilum RC organisms by dounce
homogenization and OptiPrep density-gradient centrifugation.
In Chapter 5, we discovered that the destroyed RCs and host cell debris generated
from sonication was a problem when selecting for DC organisms. As an alternative, we
chose to test dounce homogenization as a method for RC and DC isolation, as this is a
gentler manner of cell lysis. This method combined with density-gradient centrifugation
has been successful in isolating mitochondria, lysosomes and other organelles from various
cells and tissue (60-62), as well as for isolation of Neorickettsia risticii (104). In an effort
to lyse infected cells while keeping the A. phagocytophilum RC and DC undamaged, and
reduce host cell debris contamination, we tested the efficiency of dounce homogenization.
Infected HL-60 cells were first placed in a hypo-osmotic solution to make them
more susceptible to lysis from swelling. Cells were lysed by dounce homogenization after
which they were returned to an iso-osmotic state to prevent damage to the organisms and
host cell vesicles. Large cellular debris was removed by differential centrifugation, after
which the recovered organisms were centrifuged through an OptiPrep discontinuous
density-layered gradient. We used OptiPrep in our gradients because the Renografin
solution we used previously in Chapter 5 was no longer commercially available. After
centrifugation, we analyzed several interfaces of the gradient by TEM and found that the
25% - 30% interface was the only layer that contained pure bacteria (Fig. 20). The 25% 30% interface was enriched for RC organisms with minimal host cell debris contamination.
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Figure 20. A. phagocytophilum RC organisms recovered by dounce homogenization
and density-gradient centrifugation. Infected host cells were dounce homogenized and
Ap organisms were purified by OptiPrep discontinuous density-gradient centrifugation.
(A-C) TEM images of organisms recovered between the 25% - 30% OptiPrep interface.
Results from 3 separate experiments are shown. Scale bar 2 µm.
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None of the other analyzed layers contained any abundance or purity of DC organisms
(data not shown).

Attempts to isolate and purify A. phagocytophilum DC organisms by syringe lysis and
OptiPrep density-gradient centrifugation.
Our TEM results revealed that dounce homogenization only recovered an RCenriched bacterial population. Therefore, we had to try alternative approaches of lysing
infected cells to maximize recovery of DC organisms. We previously determined that
syringe lysis is best suited for recovery of a mixture of both RC and DC organisms as seen
in Figure 18B of Chapter 5.
To recover DC organisms, we repeatedly passed infected HL-60 cells through a
18½ and 27½ gauge needles to destroy the host cell and release intact RC and DC A.
phagocytophilum organisms.

Large cellular debris was removed by differential

centrifugation, after which the recovered organisms were centrifuged through an OptiPrep
discontinuous density-layered gradient.

After centrifugation, we analyzed several

interfaces of the density-gradient by TEM and found that the 20% - 25% interface
contained the greatest abundance of bacteria (Fig. 21). The first time we tested this
approach, we recovered a fairly pure population of DC organisms with little to no RCs
(Fig. 21A). However, repeated attempts to recover this DC-enriched population were
unsuccessful, as only a mixed population of RC and DC organisms were recovered (Fig.
21B and C).
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Figure 21. Attempts to purify A. phagocytophilum DC organisms by syringe lysis and
density-gradient centrifugation. Infected host cells were syringe lysed and organisms
were purified by OptiPrep discontinuous density-gradient centrifugation.

(A-C) TEM

images of organisms recovered between the 20% - 25% OptiPrep interface. Results from 3
separate experiments are shown. Scale bar 2 µm.
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DISCUSSION
These approaches were designed to isolate organisms from HL-60 cells while
keeping the RC undamaged, as to prevent destroyed RC debris from comigrating and
contaminating recovered DC organisms. We observed that dounce homogenization and
density-gradient purification was suited for recovery of intact RC organisms and greatly
reduced cellular debris contamination compared to that observed when using sonication in
Chapter 5 (Fig. 19). Using this approach we obtained an RC-enriched bacterial population
(Fig. 20), but unfortunately did not recover any significant population of DCs.

We

determined that the lack of recovered DC organisms was a result of how the cells were
lysed. We know dounce homogenization releases A. phagocytophilum organisms from
their inclusions, as indicated by the recovered RC-enriched population. But we also know
the host cells are gently lysed, which keeps many large membrane and cellular structures
intact, including the host cell nucleus. We think that as the A. phagocytophilum inclusions
are broken open and the bacteria are released, the adherent DC organisms most likely binds
to PSGL-1 on intact membrane cellular debris. This large cellular debris is removed by
differential centrifugation before it is ever added to the OptiPrep discontinuous densitygradient, thus potentially preventing recovery of DC organisms. Indeed, others have noted
that intracellular organisms adhere persistently to host cell material (190, 198). We also
observed that the recovered RC organisms migrate at the 25% - 30% interface. We
ascertained that as the infected HL-60 cells are treated with the hypo-osmotic solution to
aid in their lysis, the density of RC organisms' increases, which "shifts" the majority of the
RC population to the 25% - 30% interface. This in fact results in a more consistently
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recovered RC-enriched population with minimal cellular debris contamination (Fig. 20).
A few DC organisms can be observed within the RC-enriched population, but their
presence is minimal.
In spite of the fact that purification of the A. phagocytophilum RC is of great
benefit, our intent was to purify DC organisms. Therefore, we next used syringe lysis to
isolate organisms from infected cells, which we know recovers both intact RC and DC
organisms, as previously demonstrated in Chapter 2 (Table 1) and Chapter 5 (Fig. 18B).
Syringe lysis is more destructive to HL-60 cells and efficiently destroys host cell
membrane structures, which ensures recovery of DC organisms. Syringe lysis will result
in more cellular debris contamination, but is a necessity to ensure DC recovery. The first
time we tested syringe lysis with OptiPrep discontinuous density-layered gradients, we
recovered a DC-enriched bacterial population with little to no RC organisms at the 20% 25% interface (Fig. 21A). Unfortunately, repeated attempts following the same protocol
resulted in recovery of a mixed RC and DC bacterial population (Fig. 21B and C). There
could be several reasons for these discrepancies between experiments.

First, the

population of DC organisms within the cultures during the first experiment may have
simply been much greater.

Second, it could be a consequence of the biphasic

developmental cycle exhibited by A. phagocytophilum.

The constant transitional

continuum between RC and DC forms may prevent them from having a consistent density
to allow for individual separation. We have observed by TEM that DC organisms stopped
at the 20%, 25%, and 30% layers of the OptiPrep density gradients (data not shown)
thereby validating that the density of the organisms can vary. Although the majority of the
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DCs migrate to the 20% - 25% interface, the DC that migrates elsewhere is too few to
pursue.

This variation in density contributes to an overall loss in recovery of DC

organisms.
An assortment of attempts to remove the RC organisms from the DC were taken.
These included, but were not limited to changing the speed of density-gradient
centrifugation, as well as adding more or less density gradient layers, which were all
unsuccessful. We learned during dounce homogenization that the hypo-osmotic solution
used to aid in cell lysis "shifted" the RCs to the 25% - 30% interface. Since the DC was
resistant to sonication, we thought they may also be resistant to osmotic changes as well.
We tried treating the mixed bacterial population recovered by syringe lysis at the 20% 25% interface with the hypo-osmotic solution, then centrifuged the sample through a
second OptiPrep discontinuous density-gradient to determine if we could "shift" the RC
organisms at the 20% - 25% interface to the 25% - 30% interface, while leaving the DC at
the 20% - 25% interface. Although many RC organisms were "shifted" to the 25% - 30%
interface, some DC organisms "shifted" as well. This resulted in fewer DC at the 20% 25% interface, which was still was contaminated with a few RCs and a fair amount of
cellular debris. Overall, the approaches we took to remove RC organisms and cellular
debris were unsuccessful in obtaining sufficient quantities of pure DC organisms.

METHODS
OptiPrep density-gradient purification of A. phagocytophilum RC organisms by
dounce homogenization. Infected HL-60 cells were pelleted at 500 x g for 10 min at 4°C.
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The supernatant was discarded and cell pellets were resuspended at a ratio of 250 x 106
cells in 50 ml cold PBS and centrifuged at 500 x g for 8 min at 4°C to wash the cells. The
supernatant was discarded and cells were resuspended at a ratio of 100 x 106 cells in 2 ml
of hypo-osmotic solution (10 mM hepes, 10 mM potassium chloride [KCl], 1.5 mM
magnesium chloride [MgCl2]) and placed on ice for 10 min. Up to 7 ml at a time was
placed in a dounce homogenizer (Kimble and Chase; Vineland, NJ, Part No. 885303-0007)
and dounced with a tight fitting pestle (Kimble and Chase, Part No. 885302-0007) 20
times. Immediately after douncing, 1/3 of the total volume of a cold 1 M Sucrose solution
(10 mM hepes, 10 mM KCl, 1.5 mM MgCl2, 1 M sucrose) was added to the dounced cells
to return the solution to an iso-osmotic state of 0.25 M sucrose. Dounced cells were
resuspended at a ratio of 100 x 106 cells in 45 ml of cold 0.25 M sucrose solution (10 mM
hepes, 10 mM KCl, 1.5 mM MgCl2, 0.25 M sucrose) and centrifuged at 1,000 x g for 10
minutes at 4°C to pellet large cellular debris. Supernatant was transferred to a new 50 ml
tube and Ap organisms were pelleted at 4,500 x g for 15 minutes at 4°C. The supernatant
was discarded and the Ap pellet was resuspended at ratio of 500 x 106 cells in 6 ml cold
0.25 M sucrose solution. DNAse I (Roche; Indianapolis, IN, Cat. No. 10104159001) was
added to a final concentration of 250 µg/ml and incubated at 37°C for 30 min. The sample
was added onto a discontinuous density-layered OptiPrep (Sigma-Aldrich; St. Louis, MO,
Cat. No. 1556-250) gradient. OptiPrep solution was diluted with the 0.25 M sucrose
solution. The OptiPrep discontinuous density-gradient was layered bottom to top with the
following volumes and percentages of OptiPrep solutions; 6 ml of 30%, 5 ml of 25%, 5 ml
of 20%, 3.5 ml of 17.5%, 3.5 ml of 15% and 3.5 ml of 12.5%. Solutions were layered in
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35 ml ultracentrifuge tubes (Beckman Coulter; Brea, CA, Part No. 344058). Samples were
centrifuged at 87,000 x g in an ultracentrifuge swinging bucket rotor for 1 hour and 15
minutes at 4°C. After centrifugation, the bands at the 25% - 30% interface were recovered
and mixed with an equal volume of sucrose-phosphate-glutamate (SPG) buffer (0.25 M
Sucrose, 7 mM KH2PO4, 3.7 mMK2HPO4, 5 mM L-glutamine [pH 7]). The sample was
centrifuged at 15,000 x g for 10 min at 4°C. The supernatant was discarded and Ap pellet
was processed for TEM as previously described (173).

OptiPrep density-gradient purification of A. phagocytophilum RC and DC organisms
by syringe lysis. Infected HL-60 cells were pelleted at 5,000 x g for 15 min at 4°C. The
supernatant was discarded and the cell pellet was resuspended in a total of 9 ml cold PBS
with protease inhibitors (Roche; Indianapolis, IN, Cat. No. 11836153001) for every 250 x
106 cells. Cells were lysed by 5 passages through 18½ and 27½ gauge needles (BD;
Franklin Lakes, NJ, Cat. Nos. 305196, 305109) in a 50 ml tube.

The sample was

distributed at a ratio of 100 x 106 cells in 45 ml PBS, and centrifuged at 1,200 x g for 10
minutes at 4°C to pellet large debris. The supernatant was transferred to new tube and
centrifuged at 4,500 x g for 15 minutes at 4°C to pellet Ap. The supernatant was discarded
and the Ap pellet was resuspended at ratio of 500 x 106 cells in 6 ml cold 0.25 M sucrose
solution (10 mM hepes, 10 mM KCl, 1.5 mM MgCl2 and 0.25 M sucrose). DNAse I
(Roche, Cat. No. 10104159001) was added to a final concentration of 250 µg/ml and
incubated at 37°C for 30 min. The sample was processed as described above except that
organisms were recovered from the 20% - 25% interface.
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CHAPTER 7: Characterization of Putative A. phagocytophilum
Dense-Cored Cell Outer Membrane Proteins

INTRODUCTION
Even though the main focus of Chapters 5 and 6 were to improve upon recovery of
DC organisms, several proteins identified in Chapter 5 were a priority to study while we
continued to test new gradient procedures. In Chapter 5, we used biotinylation to identify
surface proteins of A. phagocytophilum DC organisms. Using this approach, we identified
known OMPs of A. phagocytophilum as well as OMPs identified for other Anaplasma
species.

We rationalized that since we identified known OMPs, some of the newly

identified proteins were most likely newly discovered OMPs. Three hypothetical proteins
recovered by biotinylation and identified by MS (Table 5) were of interest. These proteins
were APH_1235, APH_0248 and APH_0853. These proteins have little to no homology
with other bacterial species. Since we presume that we are looking for unique proteins as
adhesins to human PSGL-1, these proteins were of great interest to us and we set out to
further characterize these proteins as putative DC cell OMPs.
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RESULTS
APH_1235 and APH_0248.
Two proteins of interest recovered by MS in significant enough quantities to
designate them as authentic proteins were APH_1235 and APH_0248. APH_1235 was the
second most abundant protein identified by MS (Table 5) after the dominant surface
protein of A. phagocytophilum, Msp2(P44). Both APH_1235 and APH_0248 are small
proteins.

APH_1235 is 14.7 kDa, while APH_0248 is 13.8 kDa.

We initiated our

characterization of APH_1235 and APH_0248 by expressing them as GST fusion proteins
in E. coli and using the recombinant proteins to raise mouse polyclonal antisera. We next
screened A. phagocytophilum synchronously infected HL-60 cells with anti-APH_1235
and anti-APH_0248 in conjunction with an Ab against Msp2(P44), which is a
constitutively expressed OMP. The synchronously infected cells were screened at 18 h
when the organisms should be a highly pure RC population, and 24 h, which is when DC
organisms first begin to appear (Fig. 22). At 18 h and 24 h, 0% and 21% of inclusions,
respectively, expressed APH_1235. At 18 h and 24 h, 97% and 100% of inclusions,
respectively, expressed APH_0248.

This suggests that APH_1235 is a DC-specific

protein, and APH_0248 is expressed on RC and DC organisms.

APH_0853
One very unique protein we identified, although it is just below the threshold of
authenticity as determined by MS, was hypothetical protein APH_0853. When searched
against The National Center for Biotechnology Information (NCBI) protein database using
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the basic local alignment search tool (BLAST), this 10.8 kDa protein did not have
homology to any single protein (Fig. 23A). Because of the uniqueness of APH_0853, we
decided to compare the DNA sequence of our A. phagocytophilum strain to

A.

phagocytophilum-Variant 1 (ApVar-1). ApVar-1 is a strain of A. phagocytophilum that
does not infect mice or human cell lines (114, 115). The reservoir in nature is believed to
be White-tailed deer, although goats are also susceptible to infection (113). The ApVar-1
strain is cultivated in tick cell lines for laboratory studies (112).
Although this strain cannot infect human cell lines, we do not yet know if it can
bind human PSGL-1. Nonetheless, we compared the sizes of PCR products from 5 fulllength putative OMP genes identified by biotinylation (Table 5). The only gene that had
an obvious size difference was aph_0853 (Fig 23B). We next sequenced aph_0853 from
ApVar-1 (genome sequence not yet available) and compared its DNA sequence and
translated protein sequence to those of the NCH-1 strain, which is infectious for humans.
We found that the aph_0853 gene of ApVar-1 had several point mutations as well as large
and small insertions (Fig 24A). If this protein were expressed, it would be nonfunctional
as the mutations in the DNA sequence produce a premature stop codon at amino acid 17,
which would result in a 1.9 kDa protein. This data demonstrates that APH_0853 is
expressed in an A. phagocytophilum strain that infects humans, but is severely truncated in
a stain that cannot infect human cells.
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Figure 22. APH_1235 and APH_0248 expression during intracellular infection. HL60 cells were synchronously infected with A. phagocytophilum. At 18 h (A-C and G-I)
and 24 h (D-F and J-L) post-infection, cells were fixed with methanol and viewed by
immunofluorescence microscopy for immunoreactivity with antibodies against Msp2(P44);
used to denote bacteria in A, D, G and J), anti-APH_1235 (B and E) and anti-APH_0248
(H and K). Merged fluorescent images with DAPI (stains host cell nuclei) are presented in
C, F, I and L. Representative images from 1 experiment are shown.
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Figure 23. APH_0853 BLAST search and PCR results. (A) Result of APH_0853
protein BLAST search of the NCBI database. (B) PCR products of full length genes were
compared between a human infectious A. phagocytophilum (Ap) strain and the non human
strain (ApVar-1).
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Figure 24.

DNA and protein sequences of APH_0853.

(A) Alignment of DNA

sequences of full length aph_0853 of the human infectious A. phagocytophilum (Ap) strain
and the non human strain (ApVar-1). (B) Alignment of amino acid sequence of the two
strains. Red asterisks indicate homology and blue bold text indicate differences between
the two strains.
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A.
Ap
ApVar-1

Ap
ApVar-1

Ap
ApVar-1

Ap
ApVar-1

Ap
ApVar-1

Ap
ApVar-1

10
20
30
40
50
60
|
|
|
|
|
|
ATGTTGATAGATGATCATGCAGCTGATTTTTTTT-GCAAGATTATCTGTACGTTTAAGGT
ATGTTGATAGATGATCATGCAGCTGATTTTTTTTTGCAAGATTATCTGTA-GTTTAAGGT
********************************** *************** *********
70
80
90
100
110
120
|
|
|
|
|
|
AGCAAAGAGATTTAGTAGTGTAGCAGAATATGT--------------------------AGCAAAGAGATTTAATAGTGCAGCAGAATATGTGCTGATATCACTCTGTTACGGACAACT
************** ***** ************
130
140
150
160
170
180
|
|
|
|
|
|
------------------------CTTGCTGCAGATAAACACAAATCTTTACCCAGGAGC
AACTCAGTACATAAGAGTGCTATGCTCGCTGCAGATAAACACAAATCTTTACCCAGGAGC
** *********************************
190
200
210
220
230
240
|
|
|
|
|
|
GCGCTCCTCTAGGAAAGGCATGGCTCTTTCTGAGATCAACCGCATGTCCACGCAATTTTA
GCGCTCCTCTAGGAAAGGCATGGCTCTTTCTGAGATCAACCGCATGTCCATGCAATTTTA
************************************************** *********
250
260
270
280
290
300
|
|
|
|
|
|
TGCTGTTCAGCCAACATCC---CGAGATTGTGGAATAAAAAAATGCCAACACAGTAGTAG
TGCTGTT-AGCCAATATTTATATAAGACTGCGGAATAAAAAA-TGCCAATACAGTAGCAA
******* ****** **
*** ** *********** ****** ******* *
310
320
330
340
|
|
|
|
TTTTGTTTTTTATGATTTGGCACGTATGTCCGGTCCTGGTGCAACCTGA
TTTTGTTTTTTATGATTTGATACGTATGTCCGGTCCTGGTGCAACCTGA
******************* ****************************

B.
Ap
ApVar-1

MLIDDHAADFFCKIICTFKVAKRFSSVAEYVLLQINTNLYPGARSSRKGMALSEINRMST
MLIDDHAADFFLQDYL(STOP)-------------------------------------***********

Ap
ApVar-1

QFYAVQPTSRDCGIKKCQHSSSFVFYDLARMSGPGAT(Stop)
-------------------------------------
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DISCUSSION
Our data demonstrates that we have identified APH_1235 as the first DC-specific
protein of A. phagocytophilum. Although further characterization will be required to prove
that the protein is in fact an OMP, its identification as the second most abundant protein
after Msp2(P44) in our biotinylation study (Table 5) of DC organisms strongly suggests
that APH_1235 is a DC-specific protein. This is further reinforced by the lack of detection
of APH_1235 expression at 18 h (Fig. 22B), a time point at which the A. phagocytophilum
population should exclusively consist of RC organisms. However, at 24 h, a time point
concurrent with the appearance of DC organisms, APH_1235 expression is detectable (Fig.
22E). When APH_0248 expression was monitored, it was detected at both 18 and 24 h,
suggesting that this protein is expressed on both RC and DC organisms. Even though MS
identified APH_0248 from a DC-enriched population, it is not surprising that some
proteins that are on DC organisms will also be present on RCs.
Attempts to raise antiserum to APH_0853 were unsuccessful and are currently
being retried. Although we have not yet determined when this protein is expressed during
development, we have determined that it is exclusively unique to A. phagocytophilum. A
BLAST search demonstrated that APH_0853 does not have homology to a single other
protein in the NCBI database (Fig. 23A). Also, APH_0853 is non-functional in the nonhuman strain ApVar-1 due to a premature stop codon. APH_0853 is unique to the human
infectious strain of A. phagocytophilum and its recovery from DC-enriched organisms
makes this protein a priority to pursue as a potential DC-specific OMP that could function
as an adhesin.
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The manner by which these proteins are associated with the A. phagocytophilum
outer membrane is unknown. None of these proteins were predicted as OMPs by any of
the programs used in Chapter 3 to analyze the A. phagocytophilum genome. The program
CELLO, which predicted 130 potential OMPs (Table 3), classifies these 3 small proteins
as cytoplasmic (data not shown). None of the proteins contain signal sequences that would
conceivably direct them to the outer membrane when analyzed by the signalP program.
Computer analyses to look for potential transmembrane helices were inconsistent, as
programs predicted 0, 1 or 2 helices for each protein (data not shown). Lastly, since we
demonstrate that APH_1235 and APH_0248 are expressed during infection, these proteins
should no longer be classified as hypothetical proteins but instead be designated as
uncharacterized proteins.

METHODS
Recombinant protein expression and generation of antisera. Full length proteins of
interest were expressed as GST fusion proteins according to manufacturer's instructions
using the pENTR directional TOPO cloning kits pENTR/TEV/D-TOPO (Invitrogen;
Carlsbad, CA, Cat. No. K2525-20) and E. coli expression system with gateway technology
pDEST-15 (Invitrogen, Cat. No. 11802-014).

Insoluble proteins were solubilized in

Sarkosyl as previously described (168). SnakeSkin dialysis tubing (Pierce; Waltham, MA)
was used to remove detergents and place proteins into a PBS solution. Purified proteins
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were submitted for production of mouse polyclonal antiserum. Anti-GST-APH_0248 and
Anti-GST-APH_1235 is referred to as anti-APH_0248 and anti-APH_1235, respectively.

APH_1235

and

APH_0248

infection time course and

immunofluorescence

microscopy. A. phagocytophilum organisms were recovered from 10 times the number of
infected HL-60 cells by syringe lysis as described (27) and added to naïve HL-60 cells to
initiate a synchronous infection. For bacterial adherence, A. phagocytophilum organisms
were incubated at a ratio of 2.0x106 HL-60 cells in 1 ml of IMDM-10 (Invitrogen) for 1
hour. Host cells were pelleted at 300 x g for 5 min, washed twice with PBS to remove
unbound bacteria, and incubated in IMDM-10 at 37°C in 5% CO2. At 18 h and 24 h,
35,000 cells per sample were removed and centrifuged onto glass slides using a Shandon
Cytospin 4 cytocentrifuge (Thermo Scientific, Waltham, MA) as described previously
(27), followed by fixation in methanol for 4 min and stored at -20°C.
For immunofluorescence microscopy slides were blocked with 5% BSA/PBS for 1
hour. Mouse anti-APH_1235 and anti-APH_0248 sera were added for 45 min at dilutions
of 1:100 and 1:200, respectively, in 1% BSA/PBS.

The antisera were removed by

aspiration and then rabbit anti-MPB-Msp2(P44) was added for 30 min at a 1:500 dilution
in 1% BSA/PBS. The slides were washed 3 times in TBS-t (0.5%) for 2 min each,
followed by Alexa Fluor 594-conjugated goat anti-mouse IgG (Invitrogen) for 30 min at a
1:1,000 dilution in 1% BSA/PBS. The antisera were removed by aspiration and then
Alexa Fluor 488-conjugated goat anti-rabbit IgG (Invitrogen) was added for 30 min at a
1:500 dilution in 1% BSA/PBS. The slides were washed 3 times in TBS-t (0.5%) for 2
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min each, followed by mounting with Prolong Antifade Gold with 4',6-diamidino-2phenylindole (DAPI) (Invitrogen).

The cells were examined for inclusions using an

Olympus BX51 microscope. A minimum of 100 inclusions was scored per time point.

DNA sequencing and alignments. Primers were designed to amplify 5 full-length genes
of interest. The primers were as follows: APH_0248 (F) 5'-CACCATGATACCATTAGC
TCCTTGGAAGAGC-3' and (R) 5'-TTAGCTTTCTTTAGGAGTATTGGCACCGTAA-3',
APH_0625 (F) 5'-CACCATGACCGGAGTGTACTATTCCATTGGTG-3' and (R) 5'CTAGCCTGTTATTAGACCAAAGTCTCTATAAAACTTTTCTGC-3', APH_0853 (F)
5'-CACCATGTTGATAGATGATCATGCAGCTGATTTTT-3' and (R) 5'-TCAGGTTG
CACCAGGACC-3', APH_1049 (F) 5'-CACCTATGTTAACAAAAAGGGAATATTCAG
TGACATGGG-3' and (R) CTAAGAATTAAGGTACTTATTAACGAAATCAAAAAGT
CTACCTACT-3', and APH_1235 (F) 5'-CACCATGAAAGGAAAGTCAGATTCTGAAA
TACGTACG-3' and (R) 5'-CTAACCTTGGGTCGATGCCACAATTTTC-3'.
underlined nucleotides correspond to a Gateway-compatible sequence.

The

Genes were

amplified from the NCH-1 strain, which is infectious for humans, and the non-human
strain ApVar-1. PCR size products were compared by agarose gel electrophoresis. PCR
products for aph_0853 from ApVar-1 were cloned into the pENTR/TEV/D-TOPO cloning
vector (Invitrogen, Cat. No. K2525-20). The insert sequences were sequenced and verified
as correct.
Sequence alignments of APH_0853 were aligned using the http://npsapbil.ibcp.fr/cgi-bin/npsa_automat.pl?page=/NPSA/npsa_clustalwan.html
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program

for

protein

and

http://npsa-pbil.ibcp.fr/cgi-bin/npsa_automat.pl?page=/NPSA/npsa_clustal

wan.html for DNA.
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CHAPTER 8: Conclusions

The results of this dissertation highlight the unusual and complex features of A.
phagocytophilum. We characterized many important features about adhesion to PSGL-1
and potentially identified the first DC-specific A. phagocytophilum OMP. Previous work
largely suggests that the A. phagocytophilum adhesins are surface exposed proteins. Our
work was able to further demonstrate that the A. phagocytophilum DC is environmentally
resistant, and responsible for binding human PSGL-1. We have established the DC's role
as the adherent/infectious form of A. phagocytophilum, whereas the RC is fragile, does not
bind human PSGL-1 and is the replicative form. This is in agreement with analogous
forms of other obligate intracellular bacteria that undergo biphasic development.
Our attempts to capture adhesins by receptor crosslinking and affinity purification
met with little success. We did learn that A. phagocytophilum must adhere to immobilized
PSGL-1. The negative results from crosslinking, immunoprecipitation, and data from
other lab members demonstrate that adherence to PSGL-1 is more complex than first
realized. All of the approaches we tested have successfully identified adhesins of other
pathogens. The inability to recover A. phagocytophilum adhesin(s) either suggests that
there is a very weak affinity between the adhesin and receptor or that a multifaceted
protein complex is required for adhesion to bind PSGL-1, thus preventing its direct
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recovery by the methods employed in this study. Although we used computer predictions
to identify outer membrane proteins in this study, they mainly serve as a good reference for
comparison to experimental data. It is likely that some of these predictions are accurate,
but the focus of my dissertation was to specifically identify proteins by experimental
means. This would allow time to be spent focusing on proteins that were actually proven
to be OMPs.
Our first attempt to identify OMPs by sonication, Renografin density-gradient
purification and biotinylation was successful. We identified 3 known surface proteins as
well as those previously identified by biotinylation. It is likely that many of the proteins
we identified in our biotinylation approach are DC-specific.

However, some of the

identified proteins may have come from RC organisms. Consequently, we had to devise
and test new gradient procedures using new and untested approaches.
Our expectation of using discontinuous density-gradient centrifugation to purify
DC organisms was partially successful. The best results we obtained thus far are recovery
of mixed populations of RC and DC organisms from syringe lysis. These organisms are
contaminated with less cellular debris after gradient-centrifugation than if they were
isolated by syringe lysis alone. Although not ideal, they can still serve as a template in
biotinylation studies to identify surface proteins. This would identify surface proteins on
both developmental forms, but will still provide a list of proteins on which to focus our
attention.

Although we may try to improve these gradient procedures, the continual

transition between RC and DC organisms may prevent us from ever recovering a pure DC
bacterial population.
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Future directions
If we cannot isolate pure DC organisms by discontinuous density-gradient
centrifugation, then there is an alternative approach that we will try. We can use the
adherent property of the DC as a means to isolate it from RC organisms and cellular debris.
We know that A. phagocytophilum organisms will bind to rhPSGL-1 immobilized to
ELISA plates. We could isolate organisms by syringe lysis, and incubate them over a plate
coated with rhPSGL-1. Only adherent DC organisms will bind to rhPSGL-1, thereby
allowing for RC organisms and cellular debris to be washed away. DC organisms can then
be scrapped off the plate and pelleted.

Although theoretically possible, the yield of

recovered DC organisms may be minimal and, if so, would require large-scale application.
Identification of putative OMPs in Chapter 5 and characterization of APH_1235
and APH_0248 in Chapter 7 demonstrates the strength of biotinylation to identify new
proteins.

If additional work confirms APH_1235 and APH_0248 as OMPs, it will

reinforce the argument that some OMPs of A. phagocytophilum will have to be discovered
by experimental methods and cannot be predicted. As mentioned above, use of mixed RC
and DC organisms recovered from OptiPrep discontinuous density-gradient centrifugation
still serves as a valuable resource for biotinylation studies to identify OMPs. We do not
know how many proteins are differently expressed between the RC and DC. All we know
for certain is that the DC upregulates or optimally modifies proteins allowing them to
functions as adhesins. If a list of OMPs is generated from both RC and DC organisms,
there are ways that we could narrow down on which proteins to focus our attention. Once
antiserum is generated against a protein of interest, we can screen a lysate of the RC146

enriched bacteria and compare it to a lysate of both RC and DC organisms. Presumably,
any surface protein that functions as an adhesin should be detected in the lysate of mixed
organisms but not in the RC-enriched lysate. A similar approach would be to monitor
genes of interest by real-time PCR over the course of a synchronous infection. Genes
expressed late in development, concurrent with the appearance of DC organisms would be
a priority to study.
Another potential approach that we could try is to reduce the list of OMPs by
comparing the DNA sequence of our NCH-1 and other strains that infect human cells to
that of ApVar-1. If and only if the ApVar-1 does not bind human PSGL-1, it would imply
that one or more proteins are missing or mutated on the ApVar-1 surface, thereby resulting
in the loss of adhesion to human cells. A direct comparison between ApVar-1 and our
human strains may allow for identification of putative adhesins. A prime example is
protein APH_0853.
Purification of the A. phagocytophilum RC will be invaluable for future
experiments. Even though our focus was to identify OMPs using these purified organisms,
we have the added bonus of using them to obtain the RC proteome. This will provide great
knowledge into which proteins are involved in replication, metabolism, and potentially
identify virulence proteins required for intracellular survival. If DC organisms can be
purified in the future, characterization of their proteome will potentially identify
prepackaged effector proteins and other proteins that are crucial during the early stages of
binding and infection. Purification of the A. phagocytophilum RC is a vital step forward in
this direction.

Characterization of the two developmental forms will allow for
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identification of RC and DC specific markers. This was indeed the case for the purified
developmental forms of Coxiella burnetii (36). Two highly upregulated proteins were
found to be associated with the infectious SCV (71, 72), and have since been identified as
DNA-binding proteins that are only present in the compacted chromatin of the infectious
SCV. Presumably A. phagocytophilum has proteins of similar function. We have since
tested improved urea-based lysis buffers, which greatly enhances solubilization of purified
samples compared to RIPA. Complete solubilization of samples will be critical to recover
all the proteins associated with each developmental form. APH_1235 is likely an OMP;
and preliminary data suggests that it is DC specific. If APH_1235 is confirmed as DCspecific, it will serve as the first maker to distinguish between the two A. phagocytophilum
developmental forms.

This will allow us to rapidly distinguish between forms, thus

eliminating the need to confirm experimental results by TEM.
A long term goal of the Carlyon lab is to identify OMPs as adhesins to the
confirmed human receptor PSGL-1.

Though it may take some time to identify and

specifically prove an OMP as an adhesin to human PSGL-1, any OMPs we identify in the
process will be of great value.

At this time very little is known about how A.

phagocytophilum is transmitted from a tick and infects a host. I believe that DC organisms
are transferred in some fashion from the tick to the host during a blood meal. Ticks feed
on a variety of mammals and I do not believe A. phagocytophilum has the ability to know
the host it will next infect. This implies the A. phagocytophilum DC must have the
adhesins on its surface ready to bind many diverse receptors. As mentioned earlier, we
have observed by TEM the infectious DC form of A. phagocytophilum isolated from HL148

60 cells binding to mouse mast cells (unpublished data). Because the DC is presumably
metabolically inactive, it would not have the ability to upregulate proteins specific to the
host into which it was just transmitted. This strongly implicates that the adhesin(s) for
multiple cells types are likely expressed on the DC surface.
I believe that A. phagocytophilum has a select number of adhesins that
cooperatively act in various combinations that allow the organisms to bind to a variety of
different receptors, resulting in infection of various cell types within mammalian and tick
hosts. Therefore, if an identified surface protein does not function as an adhesin to human
PSGL-1, it may be equally important in infection of another mammal.

Nonetheless,

identification of other proteins as adhesins of human PSGL-1 will have great value and
application to other organisms. Fucosylation of human, mouse and tick cells lines is
critical for A. phagocytophilum infection (29, 137, 194).

If the bacterial adhesin

responsible for binding fucose on human PSGL-1 is identified, it will have broad
implications for protection against A. phagocytophilum infection of more than humans
alone. Further identification and characterization of A. phagocytophilum surface exposed
proteins will greatly enhance our understanding of mammalian infection by this potentially
fatal tick-transmitted pathogen.
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